☰

Dawn L. Hershman - Publications

Affiliations: 
Epidemiology Columbia University, New York, NY 
Area:
Epidemiology, Finance, Public Health, Health Care Management
Tree Info Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Dioun S, Chen L, De Meritens AB, St Clair CM, Hou JY, Khoury-Collado F, Pua T, Hershman DL, Wright JD. Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy. Gynecologic Oncology. 182: 70-74. PMID 38262241 DOI: 10.1016/j.ygyno.2023.12.027  0.306
2023 Accordino MK, Lee S, Leu CS, Levin B, Trivedi MS, Crew KD, Kalinsky K, Raghunathan R, Faheem K, Harden E, Taboada A, de Oliveira BD, Larson E, Franks L, Honan E, ... ... Hershman DL, et al. Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer. Breast Cancer Research and Treatment. PMID 38060077 DOI: 10.1007/s10549-023-07172-y  0.344
2023 Yeh C, Zhou M, Bapodra N, Hershman D, Espinal E, Moran M, Rivero M, Fojo AT, Bates SE. Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials. Breast Cancer Research and Treatment. PMID 37955764 DOI: 10.1007/s10549-023-07131-7  0.309
2023 Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, ... ... Hershman DL, et al. Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study. Elife. 12. PMID 37846664 DOI: 10.7554/eLife.82618  0.307
2023 Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Bliss JM, Rastogi P, Rabaglio-Poretti M, Thompson AM, Rea DW, et al. Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300296. PMID 37695982 DOI: 10.1200/JCO.23.00296  0.379
2023 Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li FY, Ferrucci LM, Puklin L, Cao A, Nguyen TH, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones BA, Knobf T, et al. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300871. PMID 37656930 DOI: 10.1200/JCO.23.00871  0.335
2023 Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, et al. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment. PMID 37326764 DOI: 10.1007/s10549-023-06997-x  0.318
2023 Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, ... ... Hershman DL, et al. Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Medrxiv : the Preprint Server For Health Sciences. PMID 37205429 DOI: 10.1101/2023.03.09.23287038  0.361
2023 Odai-Afotey A, Lederman RI, Ko NY, Gagnon H, Fikre T, Gundersen DA, Revette AC, Hershman DL, Crew KD, Keating NL, Freedman RA. Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment. 200: 127-137. PMID 37178432 DOI: 10.1007/s10549-023-06960-w  0.342
2023 Hershman DL, Chen BE, Sathe C, Parulekar WR, Lemieux J, Ligibel JA, Gelmon KA, Whelan TJ, Goodwin PJ. Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment. PMID 37157006 DOI: 10.1007/s10549-023-06922-2  0.313
2023 Sathe C, Accordino MK, DeStephano D, Shah M, Wright JD, Hershman DL. Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment. PMID 37157005 DOI: 10.1007/s10549-023-06957-5  0.328
2023 Cannioto RA, Attwood KM, Davis EW, Mendicino LA, Hutson A, Zirpoli GR, Tang L, Nair NM, Barlow W, Hershman DL, Unger JM, Moore HCF, Isaacs C, Hobday TJ, Hortobagyi GN, et al. Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer. Jama Network Open. 6: e2311673. PMID 37140922 DOI: 10.1001/jamanetworkopen.2023.11673  0.351
2023 Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, et al. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Research Square. PMID 36993531 DOI: 10.21203/rs.3.rs-2675372/v1  0.318
2022 Boone RM, Praiss AM, Huang Y, Melamed A, Khoury-Collado F, Hou JY, Gockley A, St Clair CM, Hershman DL, Wright JD. Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. Gynecologic Oncology. 169: 70-77. PMID 36521351 DOI: 10.1016/j.ygyno.2022.11.022  0.321
2022 Freedman RA, Ko NY, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL. Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Research and Treatment. PMID 36220997 DOI: 10.1007/s10549-022-06752-8  0.331
2022 Cogan JC, Raghunathan RR, Beauchemin MP, Accordino MK, Huang Y, Elkin EB, Melamed A, Wright JD, Hershman DL. New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer. Journal of the National Cancer Institute. PMID 36130058 DOI: 10.1093/jnci/djac170  0.316
2022 Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Bliss JM, Rastogi P, Rabaglio-Poretti M, Mukherjee SD, Mackey JR, et al. Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. Jama. 327: 1963-1973. PMID 35608580 DOI: 10.1001/jama.2022.6147  0.352
2022 McGuinness JE, Ro V, Mutasa S, Pan S, Hu J, Trivedi MS, Accordino MK, Kalinsky K, Hershman DL, Ha RS, Crew KD. Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer. Breast Cancer Research and Treatment. PMID 35575954 DOI: 10.1007/s10549-022-06614-3  0.317
2022 Greenlee H, Iribarren C, Rana JS, Cheng R, Nguyen-Huynh M, Rillamas-Sun E, Shi Z, Laurent CA, Lee VS, Roh JM, Santiago-Torres M, Shen H, Hershman DL, Kushi LH, Neugebauer R, et al. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101736. PMID 35385342 DOI: 10.1200/JCO.21.01736  0.331
2022 Gamble CR, Chen L, Szamreta E, Monberg M, Hershman D, Wright J. Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer. Archives of Gynecology and Obstetrics. PMID 34993579 DOI: 10.1007/s00404-021-06282-6  0.32
2022 Shankaran V, Unger JM, Darke AK, Suga JM, Wade JL, Kourlas PJ, Chandana SR, O'Rourke MA, Satti S, Liggett D, Hershman DL, Ramsey SD. S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients. Journal of the National Cancer Institute. PMID 34981117 DOI: 10.1093/jnci/djab210  0.319
2021 Zhou ZN, Chen L, Melamed A, St Clair CM, Hou JY, Khoury-Collado F, Gockley A, Hershman DL, Wright JD. Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. Gynecologic Oncology. PMID 34920885 DOI: 10.1016/j.ygyno.2021.12.005  0.336
2021 Melamed A, Rauh-Hain JA, Gockley AA, Nitecki R, Ramirez PT, Hershman DL, Keating N, Wright JD. Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. Jama Oncology. PMID 34591081 DOI: 10.1001/jamaoncol.2021.4252  0.351
2021 Goodwin PJ, Dowling RJO, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Gelmon KA, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Rabaglio-Poretti M, Lemieux J, et al. Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo. Jnci Cancer Spectrum. 5: pkab066. PMID 34485814 DOI: 10.1093/jncics/pkab066  0.324
2021 Sanft T, Harrigan M, Cartmel B, Ferrucci LM, Li FY, McGowan C, Zupa M, Nguyen TH, Ligibel J, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones B, Knobf T, Chagpar A, et al. Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial. Contemporary Clinical Trials. 106508. PMID 34274495 DOI: 10.1016/j.cct.2021.106508  0.35
2021 Hopson MB, Lee S, Accordino M, Trivedi M, Maurer M, Crew KD, Hershman DL, Kalinsky K. Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer. Breast Cancer Research and Treatment. PMID 33837871 DOI: 10.1007/s10549-021-06210-x  0.369
2021 Unger JM, Moseley AB, Cheung CK, Osarogiagbon RU, Symington B, Ramsey SD, Hershman DL. Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002602. PMID 33729825 DOI: 10.1200/JCO.20.02602  0.317
2021 Hershman DL, Neugut AI, Moseley A, Arnold KB, Gralow JR, Henry NL, Hillyer GC, Ramsey SD, Unger JM. Patient Reported Outcomes and Long-Term Non-Adherence to Aromatase Inhibitors. Journal of the National Cancer Institute. PMID 33629114 DOI: 10.1093/jnci/djab022  0.303
2021 Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, Regan MM, Spears PA, Sudheendra PK, Symmans WF, Yung RL, ... ... Hershman DL, et al. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003399. PMID 33507815 DOI: 10.1200/JCO.20.03399  0.303
2020 Blanco M, Chen L, Melamed A, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Cost of Care for the Initial Management of Cervical Cancer in Women with Commercial Insurance. American Journal of Obstetrics and Gynecology. PMID 32818476 DOI: 10.1016/J.Ajog.2020.08.039  0.39
2020 Wu J, Huang Y, Tergas AI, Melamed A, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Hershman DL, Wright JD. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer. Gynecologic Oncology. PMID 32800656 DOI: 10.1016/J.Ygyno.2020.08.006  0.389
2020 Knisely A, Wu J, Kaplan SJ, Zhou ZN, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Huang YY, Hershman DL, Wright JD. Coronavirus Spectrum Infections (COVID-19, MERS, SARS) in Cancer Patients: A Systematic Review of the Literature. Cancer Investigation. 1-23. PMID 32787597 DOI: 10.1080/07357907.2020.1809668  0.379
2020 Huang Y, Jacobson JS, Tergas AI, Ananth CV, Neugut AI, Hershman DL, Wright JD. Insurance-Associated Disparities in Opioid Use and Misuse Among Patients Undergoing Gynecologic Surgery for Benign Indications. Obstetrics and Gynecology. PMID 32769642 DOI: 10.1097/Aog.0000000000003948  0.301
2020 Unger JM, Hershman DL, Osarogiagbon RU, Gothwal A, Anand S, Dasari A, Overman M, Loree JM, Raghav K. Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies. Jnci Cancer Spectrum. 4: pkaa034. PMID 32704619 DOI: 10.1093/Jncics/Pkaa034  0.402
2020 Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, Schneider BP, Lavoie Smith EM, Smith ML, Smith TJ, Wagner-Johnston N, ... Hershman DL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001399. PMID 32663120 DOI: 10.1200/Jco.20.01399  0.353
2020 Wong SF, Unger JM, Wade JL, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, ... ... Hershman DL, et al. A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. Journal of Patient-Reported Outcomes. 4: 54. PMID 32642992 DOI: 10.1186/S41687-020-00220-X  0.352
2020 Marks DK, Gartrell RD, El Asmar M, Boboila S, Hart T, Lu Y, Pan Q, Yu J, Hibshoosh H, Guo H, Andreopoulou E, Wiechmann L, Crew K, Sparano J, Hershman D, et al. Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer. Frontiers in Oncology. 10: 968. PMID 32612958 DOI: 10.3389/Fonc.2020.00968  0.302
2020 Accordino MK, Wright JD, Buono D, Lin A, Huang Y, Neugut AI, Hillyer GC, Hershman DL. Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data. Breast Cancer Research and Treatment. PMID 32591988 DOI: 10.1007/S10549-020-05756-6  0.403
2020 Pimentel I, Chen BE, Lohmann AE, Ennis M, Ligibel J, Shepherd L, Hershman DL, Whelan T, Stambolic V, Mayer I, Hobday T, Lemieux J, Thompson A, Rastogi P, Gelmon K, et al. The effect of metformin vs placebo on sex hormones in CCTG MA.32. Journal of the National Cancer Institute. PMID 32497219 DOI: 10.1093/Jnci/Djaa082  0.395
2020 Shankaran V, Unger JM, Darke AK, Hershman DL, Ramsey SD. Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers. Contemporary Clinical Trials. 106037. PMID 32485324 DOI: 10.1016/J.Cct.2020.106037  0.369
2020 Knisely A, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL, Wright JD. Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes. Gynecologic Oncology. PMID 32456990 DOI: 10.1016/J.Ygyno.2020.05.017  0.371
2020 Kalinsky K, Accordino MK, Hosi K, Hawley JE, Trivedi MS, Crew KD, Hershman DL. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City. Breast Cancer Research and Treatment. 182: 239-242. PMID 32405915 DOI: 10.1007/S10549-020-05667-6  0.407
2020 Hershman DL, Unger JM, Hillyer GC, Moseley A, Arnold KB, Dakhil SR, Esparaz BT, Kuan MC, Graham ML, Lackowski DM, Edenfield WJ, Dayao ZR, Henry NL, Gralow JR, Ramsey SD, et al. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902699. PMID 32369401 DOI: 10.1200/Jco.19.02699  0.458
2020 Hershman DL, Till C, Wright JD, Accordino M, Vaidya R, Barlow WE, Ramsey S, Unger JM. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials. Breast Cancer Research and Treatment. PMID 32306168 DOI: 10.1007/S10549-020-05634-1  0.42
2020 Cannioto RA, Hutson A, Dighe S, McCann W, McCann SE, Zirpoli GR, Barlow W, Kelly KM, DeNysschen CA, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, et al. Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival. Journal of the National Cancer Institute. PMID 32239145 DOI: 10.1093/Jnci/Djaa046  0.444
2020 Lauren B, Ostvar S, Silver E, Ingram M, Oh A, Kumble L, Laszkowska M, Chu JN, Hershman DL, Manji G, Neugut AI, Hur C. Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting. Journal of Oncology. 2020: 2198960. PMID 32148492 DOI: 10.1155/2020/2198960  0.353
2020 Huang AB, Huang Y, Hur C, Tergas AI, Khoury-Collado F, Melamed A, Clair CMS, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD. Impact of Quality of Care on Racial Disparities in Survival for Endometrial Cancer. American Journal of Obstetrics and Gynecology. PMID 32109459 DOI: 10.1016/J.Ajog.2020.02.021  0.393
2020 Praiss AM, Huang Y, St Clair CM, Tergas AI, Melamed A, Khoury-Collado F, Hou JY, Hur C, Ananth CV, Neugut AI, Hershman DL, Wright JD. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer. Gynecologic Oncology. PMID 32094021 DOI: 10.1016/J.Ygyno.2020.02.014  0.358
2020 Pothuri B, Brodsky AL, Sparano JA, Blank SV, Kim M, Hershman DL, Tiersten A, Kiesel BF, Beumer JH, Liebes L, Muggia F. Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up. Cancer Chemotherapy and Pharmacology. PMID 32055930 DOI: 10.1007/S00280-020-04030-2  0.408
2020 Hillyer GC, Beauchemin M, Hershman DL, Kelsen M, Brogan FL, Sandoval R, Schmitt KM, Reyes A, Terry MB, Lassman AB, Schwartz GK. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients. Clinical Trials (London, England). 1740774520901514. PMID 32009456 DOI: 10.1177/1740774520901514  0.425
2020 Hershman DL, Accordino MK, Shen S, Buono D, Crew KD, Kalinsky K, Trivedi MS, Hur C, Hu J, Unger JM, Wright JD. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events. Cancer. PMID 31913500 DOI: 10.1002/Cncr.32690  0.37
2020 Shen S, Vaidya R, Darke A, Unger JM, Sedrak MS, Segarra-Vazquez B, Law C, Rowland KM, Floyd JD, Brant JM, O'Rourke MA, Beck AC, Ramsey SD, Hershman DL. Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps12126  0.35
2020 Shankaran V, Unger JM, Darke A, Suga JM, Wade JL, Kourlas P, Chandana SR, O'Rourke MA, Satti S, Liggett D, Hershman DL, Ramsey SD. Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD. Journal of Clinical Oncology. 38: 7010-7010. DOI: 10.1200/Jco.2020.38.15_Suppl.7010  0.417
2020 Fenn K, Singh VM, Lee SM, Cieremans D, Lassman AB, Hershman DL, Crew KD, Accordino MK, Trivedi MS, Iwamoto FM, Schultz R, Huynh L, Sales EV, Fisher DM, Mayer JA, et al. Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF). Journal of Clinical Oncology. 38: 3567-3567. DOI: 10.1200/Jco.2020.38.15_Suppl.3567  0.326
2020 Hershman DL, Moseley A, Arnold KB, Hillyer G, Gralow J, Henry NL, Neugut AI, Ramsey SD, Unger JM. Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105). Journal of Clinical Oncology. 38: 12019-12019. DOI: 10.1200/Jco.2020.38.15_Suppl.12019  0.471
2020 Kwan ML, Iribarren C, Neugebauer R, Rana JS, Nguyen-Huynh M, Cheng R, Shi Z, Izano M, Laurent C, Lee VS, Roh JM, Santiago-Torres M, Shen H, Hershman DL, Kushi LH, et al. Onset of cardiovascular disease risk factors in women with and without a history of breast cancer: The Pathways Heart Study. Journal of Clinical Oncology. 38: 12017-12017. DOI: 10.1200/Jco.2020.38.15_Suppl.12017  0.352
2020 Greenlee H, Iribarren C, Neugebauer R, Rana JS, Nguyen-Huynh M, Cheng R, Shi Z, Izano M, Laurent C, Lee VS, Roh JM, Shen H, Santiago-Torres M, Hershman DL, Kushi LH, et al. Risk of cardiovascular disease in women with and without a history of breast cancer: The Pathways Heart Study. Journal of Clinical Oncology. 38: 12016-12016. DOI: 10.1200/Jco.2020.38.15_Suppl.12016  0.387
2020 Shi Z, Greenlee H, Neugebauer RS, Iribarren C, Nguyen-huynh MN, Rana JS, Hershman DL, Kushi LH, Kwan ML. Abstract IA28: Disparities in cardiovascular disease incidence in breast cancer survivors Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Ia28  0.412
2020 Tsui J, DeLia D, Nova J, Stroup A, Hershman DL, Cantor J. Abstract A140: Factors associated with receipt of guideline-concordant treatment among Medicaid enrollees with breast and colorectal cancer Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-A140  0.403
2020 Ulanday KT, Santiago-Torres M, Shi Z, Paul R, Marin-Chollom A, Castellano M, Fuentes Y, Contento I, Koch P, Gray HL, Gaffney AO, Hershman D, Greenlee H. Abstract A034: Baseline characteristics of participants enrolled in a randomized controlled trial of a diet and physical activity intervention among Hispanic/Latina breast cancer survivors (in progress) Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-A034  0.377
2020 Hershman DL, Unger JM, Moseley A, Hillyer GC, Arnold KB, Gralow JR, Henry NL, Ramsey SD, Neugut AI. Abstract PD10-08: Baseline patient reported outcomes predict aromatase inhibitor adherence failure among women in enrolled in a randomized trial of text-messaging Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pd10-08  0.434
2020 Kalinsky K, Lee S, Tiersten A, Makower DF, Cigler T, Franks L, Mundi P, Chi D, Blumberg L, Sender N, Galazyn M, Hosi K, Goel A, Klein P, Andreopoulou E, ... ... Hershman DL, et al. Abstract P1-19-32: Phase I/II trial of ruxolitinib in combination with trastuzumab in HER2+ metastatic breast cancer (MBC) Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P1-19-32  0.382
2020 Altoe ML, Kalinsky K, Guo H, Hibshoosh H, Tejada M, Crew KD, Accordino MK, Trivedi MS, Marone A, Kim HK, Hielscher AH, Hershman DL. Abstract P1-01-02: Early changes in diffuse optical tomography predicts pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P1-01-02  0.433
2020 Ghersin H, Chattopadhyay A, Blaes A, Sanft T, Hershman D, Basu A, Singhrao R, Brain S, Heditsian D, Rugo HS, Esserman L, Melisko M. Abstract OT3-19-02: Introducing an electronic platform to collect patient reported outcomes in the I-SPY 2 trial, a neoadjuvant clinical trial Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-19-02  0.455
2020 Hershman D. Abstract ES8-3: Everything Comes at a Price - Toxicity, Cost and Adherence to Endocrine Therapy Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Es8-3  0.4
2019 Hopson MB, Onishi M, Awad D, Buono D, Maurer M, Crew KD, Shane E, Hershman DL, Kalinsky K. Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy. Clinical Breast Cancer. PMID 31926840 DOI: 10.1016/J.Clbc.2019.12.001  0.379
2019 Kronish IM, Cheung YK, Julian J, Parsons F, Lee J, Yoon S, Valdimarsdottir H, Green P, Suls J, Hershman DL, Davidson KW. Clinical Usefulness of Bright White Light Therapy for Depressive Symptoms in Cancer Survivors: Results from a Series of Personalized (N-of-1) Trials. Healthcare (Basel, Switzerland). 8. PMID 31905890 DOI: 10.3390/Healthcare8010010  0.339
2019 Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, et al. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901203. PMID 31855498 DOI: 10.1200/Jco.19.01203  0.474
2019 Sia TY, Chen L, Melamed A, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer. Obstetrics and Gynecology. 134: 1132-1143. PMID 31764721 DOI: 10.1097/Aog.0000000000003523  0.4
2019 Gralow JR, Barlow WE, Paterson AHG, Miao JL, Lew DL, Stopeck AT, Hayes DF, Hershman DL, Schubert MM, Clemons M, Van Poznak CH, Dees EC, Ingle JN, Falkson CI, Elias AD, et al. Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307. Journal of the National Cancer Institute. PMID 31693129 DOI: 10.1093/Jnci/Djz215  0.491
2019 Fenn K, Maurer M, Lee SM, Crew KD, Trivedi MS, Accordino MK, Hershman DL, Kalinsky K. Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer. Clinical Breast Cancer. PMID 31570268 DOI: 10.1016/J.Clbc.2019.08.004  0.372
2019 Gamble CR, Huang Y, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Quality of Care and Outcomes of Patients With Gynecologic Malignancies Treated at Safety-Net Hospitals. Jnci Cancer Spectrum. 3: pkz039. PMID 31535077 DOI: 10.1093/Jncics/Pkz039  0.319
2019 Schlechtweg K, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Melamed A, Neugut AI, Hershman DL, Wright JD. Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes. Gynecologic Oncology. PMID 31519319 DOI: 10.1016/J.Ygyno.2019.09.004  0.348
2019 Altoe ML, Marone A, Kim HK, Kalinsky K, Hershman DL, Hielscher AH, Ha RS. Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy. Biomedical Optics Express. 10: 4305-4315. PMID 31453012 DOI: 10.1364/Boe.10.004305  0.423
2019 Beauchemin M, Murray MT, Sung L, Hershman DL, Weng C, Schnall R. Clinical decision support for therapeutic decision-making in cancer: A systematic review. International Journal of Medical Informatics. 130: 103940. PMID 31450082 DOI: 10.1016/J.Ijmedinf.2019.07.019  0.32
2019 Latham AH, Chen L, Hou JY, Tergas AI, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation. Gynecologic Oncology. PMID 31395371 DOI: 10.1016/J.Ygyno.2019.07.021  0.337
2019 Barzi A, Hershman DL, Till C, Barlow WE, Ramsey S, Lenz HJ, Hochster HS, Unger JM. Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims. Archives of Osteoporosis. 14: 83. PMID 31352608 DOI: 10.1007/S11657-019-0629-7  0.308
2019 Knisely A, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL, Wright JD. Effect of Regionalization of Endometrial Cancer Care on Site of Care and Patient Travel. American Journal of Obstetrics and Gynecology. PMID 31344350 DOI: 10.1016/J.Ajog.2019.07.026  0.364
2019 Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL. Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer. Cancer Investigation. 1-9. PMID 31296072 DOI: 10.1080/07357907.2019.1624766  0.461
2019 Raab GT, Lin A, Hillyer GC, Keller D, O'Neil DS, Accordino MK, Buono DL, Hur C, Kiran RP, Wright JD, Hershman DL, Neugut AI. Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data. Clinical Colorectal Cancer. PMID 31266707 DOI: 10.1016/J.Clcc.2019.05.008  0.417
2019 Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Obstetrics and Gynecology. PMID 31188324 DOI: 10.1097/Aog.0000000000003311  0.365
2019 Syeda S, Chen L, Hou JY, Tergas AI, Khoury-Collado F, Melamed A, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer. Obstetrics and Gynecology. PMID 31188310 DOI: 10.1097/Aog.0000000000003287  0.372
2019 Wright JD, Chen L, Buskwofie A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Hur C, Neugut AI, Hershman DL. Regionalization of care for women with ovarian cancer. Gynecologic Oncology. PMID 31171408 DOI: 10.1016/J.Ygyno.2019.05.025  0.404
2019 Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers TB, Doster JE, Zarwan C, Kruper L, Minasian L, et al. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Cancer Prevention Research (Philadelphia, Pa.). PMID 31138522 DOI: 10.1158/1940-6207.Capr-18-0444  0.428
2019 Selter J, Huang Y, Grossman Becht LC, Palmerola KL, Williams SZ, Forman E, Ananth CV, Hur C, Neugut AI, Hershman DL, Wright JD. Use of Fertility Preservation Services in Female Reproductive-Aged Cancer Patients. American Journal of Obstetrics and Gynecology. PMID 31108063 DOI: 10.1016/J.Ajog.2019.05.009  0.352
2019 Wright JD, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL. Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer. Obstetrics and Gynecology. PMID 31083126 DOI: 10.1097/Aog.0000000000003288  0.399
2019 Praiss AM, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD. Safety of Same Day Discharge for Minimally Invasive Hysterectomy for Endometrial Cancer. American Journal of Obstetrics and Gynecology. PMID 31082381 DOI: 10.1016/J.Ajog.2019.05.003  0.363
2019 Neugut AI, Lin A, Raab GT, Hillyer GC, Keller D, O'Neil DS, Accordino MK, Kiran RP, Wright J, Hershman DL. FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data. Clinical Colorectal Cancer. PMID 30878317 DOI: 10.1016/J.Clcc.2019.01.005  0.438
2019 Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation. Journal of the National Cancer Institute. 111: 245-255. PMID 30856272 DOI: 10.1093/Jnci/Djy221  0.348
2019 Baglia ML, Lin IH, Cartmel B, Sanft T, Ligibel J, Hershman DL, Harrigan M, Ferrucci LM, Li FY, Irwin ML. Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors. Cancer. PMID 30840336 DOI: 10.1002/Cncr.32051  0.357
2019 Heilbroner SP, Xanthopoulos EP, Buono D, Huang Y, Carrier D, Shah A, Kim J, Corradetti M, Wright JD, Neugut AI, Hershman DL, Cheng SK. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 129: 8-15. PMID 30797496 DOI: 10.1016/J.Lungcan.2018.12.021  0.395
2019 Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL, Wright JD. Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer. American Journal of Obstetrics and Gynecology. PMID 30771346 DOI: 10.1016/J.Ajog.2019.02.019  0.446
2019 Jones NL, Huang Y, Chatterjee S, Tergas AI, Burke WM, Hou JY, Deutsch I, Ananth CV, Neugut AI, Hershman DL, Wright JD. Patterns of care and outcomes for women with uterine cancer and ovarian metastases. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 29: 365-376. PMID 30718315 DOI: 10.1136/Ijgc-2018-000047  0.43
2019 Dorsey SG, Kleckner IR, Barton D, Mustian K, O'Mara A, St Germain D, Cavaletti G, Danhauer SC, Hershman D, Hohmann AG, Hoke A, Hopkins JO, Kelly KP, Loprinzi CL, McLeod HL, et al. NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. Journal of the National Cancer Institute. PMID 30715378 DOI: 10.1093/Jnci/Djz011  0.321
2019 Leng S, Chen Y, Tsai WY, Bhutani D, Hillyer GC, Lim E, Accordino MK, Wright JD, Hershman DL, Lentzsch S, Neugut AI. Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 22-28. PMID 30659126 DOI: 10.6004/Jnccn.2018.7079  0.337
2019 Unger JM, Hershman DL, Fleury ME, Vaidya R. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation. Jama Oncology. PMID 30629092 DOI: 10.1001/Jamaoncol.2018.5953  0.39
2019 Beauchemin M, Weng C, Dupuis LL, Sung L, Hershman DL, Schnall RB. Adherence to clinical practice guidelines for the prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults with cancer receiving their first cycle of highly emetogenic chemotherapy. Journal of Clinical Oncology. 37: 19-19. DOI: 10.1200/Jco.2019.37.27_Suppl.19  0.343
2019 Hillyer G, Beauchemin M, Hershman DL, Kelsen MA, Brogan FL, Sandoval R, Schmitt KM, Reyes A, Terry MB, Lassman AB, Schwartz GK. Comparison of attitudes and beliefs about cancer clinical trial enrollment between physicians, research staff, and cancer patients. Journal of Clinical Oncology. 37: 170-170. DOI: 10.1200/Jco.2019.37.27_Suppl.170  0.437
2019 Unger JM, Moseley A, Ramsey SD, Osarogiagbon RU, Symington B, Hershman DL. Socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. Journal of Clinical Oncology. 37: 162-162. DOI: 10.1200/Jco.2019.37.27_Suppl.162  0.44
2019 Unger JM, Blanke CD, LeBlanc ML, Barlow WE, Hershman DL. Patients enrolled in clinical trials with Medicaid or no insurance and overall survival benefits from new interventions. Journal of Clinical Oncology. 37: 119-119. DOI: 10.1200/Jco.2019.37.27_Suppl.119  0.37
2019 Shankaran V, Unger JM, Darke AK, Suga JM, Wade JL, Kourlas P, Chandana SR, O'Rourke MA, Satti S, Liggett D, Hershman DL, Ramsey SD. Design and accrual of S1417CD: Development of a prospective financial impact assessment tool in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps6652  0.372
2019 Sanft TB, Harrigan M, Cartmel B, Ferrucci LM, Basen-Engquist K, Hershman DL, Ligibel JA, Neuhouser M, Chagpar AB, Jones BA, Knobf MT, Silber A, Li F, Irwin ML. A randomized trial of a healthy lifestyle intervention versus usual care on chemotherapy and endocrine therapy adherence rate in women with breast cancer: The Lifestyle Exercise and Nutrition Early After Diagnosis (LEANER) Study. Journal of Clinical Oncology. 37: TPS11633-TPS11633. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps11633  0.461
2019 Klepin HD, Garrett-Mayer E, Kaltenbaugh M, Bruinooge SS, Rubinstein WS, Meersman SC, Miller RS, Lyman GH, Gray SW, Nekhlyudov L, Osterman TJ, Thota R, Tsimberidou AM, Visvanathan K, Schilsky RL, ... Hershman DL, et al. Hypertension and use of bevacizumab among patients treated in community settings. Journal of Clinical Oncology. 37: e18279-e18279. DOI: 10.1200/Jco.2019.37.15_Suppl.E18279  0.304
2019 Unger JM, Nghiem VT, Hershman DL, Vaidya R, LeBlanc ML, Blanke CD. The impact of NCI-sponsored network group clinical trials on guideline care and new drug indications. Journal of Clinical Oncology. 37: 6604-6604. DOI: 10.1200/Jco.2019.37.15_Suppl.6604  0.312
2019 Hershman DL, Unger JM, Grace H, Moseley A, Arnold KB, Dakhil SR, Esparaz B, Kuan MC, Graham M, Lackowski DM, Edenfield WJ, Dayao ZR, Gralow J, Ramsey S, Neugut AI. Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105. Journal of Clinical Oncology. 37: 6516-6516. DOI: 10.1200/Jco.2019.37.15_Suppl.6516  0.456
2019 Pimentel I, Chen BE, Lohmann AE, Ennis M, Ligibel JA, Shepherd LE, Hershman DL, Stambolic V, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Rastogi P, Gelmon KA, Whelan TJ, et al. The effect of metformin on sex hormones in non-diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy. Journal of Clinical Oncology. 37: 529-529. DOI: 10.1200/Jco.2019.37.15_Suppl.529  0.465
2019 Unger JM, Vaidya R, Albain KS, LeBlanc ML, Minasian LM, Gotay C, Henry NL, Fisch MJ, Ramsey SD, Blanke CD, Lyman GH, Hershman DL. Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. Journal of Clinical Oncology. 37: 11588-11588. DOI: 10.1200/Jco.2019.37.15_Suppl.11588  0.364
2019 Hershman DL, Till C, Wright JD, Accordino MK, Vaidya R, Barlow WE, Ramsey S, Unger JM. Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. Journal of Clinical Oncology. 37: 11508-11508. DOI: 10.1200/Jco.2019.37.15_Suppl.11508  0.389
2019 Poznak CHV, Unger JM, Darke AK, Moinpour C, Bagramian RA, Schubert MM, Hansen LK, Floyd JD, Dakhil SR, Lew DL, Wade JL, Fisch MJ, Henry NL, Hershman DL, Gralow J. Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211. Journal of Clinical Oncology. 37: 11502-11502. DOI: 10.1200/Jco.2019.37.15_Suppl.11502  0.328
2019 Bell-Brown A, Sullivan S, Lyman G, Hershman D, Watabayashi K, Kreizenbeck K, Shirley S, Ciccarella A, Walia G, Johnson J, Seigel C, Mason G, Kurttila F, Segarra-Vazquez B, Ramsey S, et al. MA22.02 The Impact of Patient Engagement on Study Design and Patient Recruitment in a Pragmatic Trial to Improve Cancer Care Delivery Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.683  0.38
2018 Kronish IM, Fenn K, Cohen L, Hershman DL, Green P, Jenny Lee SA, Suls J. Extent of Exclusions for Chronic Conditions in Breast Cancer Trials. Jnci Cancer Spectrum. 2: pky059. PMID 31825011 DOI: 10.1093/Jncics/Pky059  0.387
2018 Chin C, Consul N, Jadeja P, Kwak E, Patel S, Wynn R, Hershman D, Connolly EP, Ha R. Utility of preoperative breast MRI in patient selection for accelerated partial breast irradiation by different consensus guidelines. The Breast Journal. PMID 30576036 DOI: 10.1111/Tbj.13185  0.362
2018 Hershman DL, Unger JM, Crew K. Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients. Jama. 320: 2270-2271. PMID 30512095 DOI: 10.1001/Jama.2018.16744  0.392
2018 Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Thomas Budd G, Albain KS, et al. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221). Breast Cancer Research : Bcr. 20: 146. PMID 30486865 DOI: 10.1186/S13058-018-1077-9  0.36
2018 Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL. Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer. Journal of Oncology Practice. JOP1800229. PMID 30407882 DOI: 10.1200/Jop.18.00229  0.457
2018 Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA, Hershman DL, Dannenberg AJ, Iyengar NM. Obesity-associated breast inflammation among Hispanic/Latina breast cancer patients. Cancer Prevention Research (Philadelphia, Pa.). PMID 30404870 DOI: 10.1158/1940-6207.Capr-18-0207  0.385
2018 Blanco C, Markowitz JC, Hellerstein DJ, Nezu AM, Wall M, Olfson M, Chen Y, Levenson J, Onishi M, Varona C, Okuda M, Hershman DL. A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer. Breast Cancer Research and Treatment. PMID 30343455 DOI: 10.1007/S10549-018-4994-5  0.4
2018 Wright JD, Chen L, Accordino M, Taback B, Ananth CV, Neugut AI, Hershman DL. Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy. Annals of Surgical Oncology. PMID 30327971 DOI: 10.1245/S10434-018-6825-7  0.363
2018 Ruiz MP, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy. Obstetrics and Gynecology. PMID 30303921 DOI: 10.1097/Aog.0000000000002912  0.304
2018 Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, et al. Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring, Md.). 26: 1539-1549. PMID 30272836 DOI: 10.1002/Oby.22269  0.398
2018 Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Hayes JF, Butler LP, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, et al. National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800242. PMID 30212295 DOI: 10.1200/Jco.18.00242  0.466
2018 Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL, Fisch MJ, Henry NL, Hershman DL. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. PMID 30159789 DOI: 10.1200/Jco.2018.36.15_Suppl.10000  0.38
2018 Nieto VL, Huang Y, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Use and Outcomes of Minimally Invasive Hysterectomy for Women with Non-Endometrioid Endometrial Cancers. American Journal of Obstetrics and Gynecology. PMID 30086293 DOI: 10.1016/J.Ajog.2018.07.028  0.418
2018 Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD. Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Medicine. PMID 30030904 DOI: 10.1002/Cam4.1657  0.322
2018 Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. Jama. 320: 167-176. PMID 29998338 DOI: 10.1001/Jama.2018.8907  0.381
2018 Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL. The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials. Cancer Epidemiology. 55: 117-122. PMID 29936140 DOI: 10.1016/J.Canep.2018.06.005  0.39
2018 Wright JD, Ruiz MP, Chen L, Gabor LR, Tergas AI, St Clair CM, Hou JY, Ananth CV, Neugut AI, Hershman DL. Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer. Obstetrics and Gynecology. PMID 29889759 DOI: 10.1097/Aog.0000000000002691  0.368
2018 Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018792721. PMID 29889605 DOI: 10.1200/Jco.2018.79.2721  0.374
2018 Selter J, Huang Y, Grossman Becht LC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Utilization of Ovarian Transposition for Fertility Preservation among Young Women with Pelvic Malignancies Who Undergo Radiotherapy. American Journal of Obstetrics and Gynecology. PMID 29883577 DOI: 10.1016/J.Ajog.2018.05.037  0.324
2018 Cui RR, Chen L, Tergas AI, Hou JY, St Clair CM, Neugut AI, Ananth CV, Hershman DL, Wright JD. Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer. Obstetrics and Gynecology. PMID 29742670 DOI: 10.1097/Aog.0000000000002613  0.409
2018 Kalinsky K, Sparano JA, Zhong X, Andreopoulou E, Taback B, Wiechmann L, Feldman SM, Ananthakrishnan P, Ahmad A, Cremers S, Sireci AN, Cross JR, Marks DK, Mundi P, Connolly E, ... ... Hershman DL, et al. Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. PMID 29736694 DOI: 10.1007/S12094-018-1888-2  0.463
2018 Deverka PA, Bangs R, Kreizenbeck K, Delaney DM, Hershman DL, Blanke CD, Ramsey SD. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies. Journal of the National Cancer Institute. PMID 29684151 DOI: 10.1093/Jnci/Djy064  0.389
2018 Kroenke CH, Hershman DL, Gomez SL, Adams SR, Eldridge EH, Kwan ML, Ergas IJ, Kubo A, Kushi LH. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Research and Treatment. PMID 29671113 DOI: 10.1007/S10549-018-4774-2  0.406
2018 Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, Unger JM. Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017774414. PMID 29584550 DOI: 10.1200/Jco.2017.77.4414  0.397
2018 Gómez-Hidalgo NR, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Hershman DL, Wright JD. Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma. Cancer Investigation. 1-9. PMID 29565689 DOI: 10.1080/07357907.2018.1449212  0.341
2018 Agrawal S, Chen L, Tergas AI, Hou JY, St Clair CM, Ananth CV, Hershman DL, Wright JD. Identifying modifiable and non-modifiable risk factors associated with prolonged length of stay after hysterectomy for uterine cancer. Gynecologic Oncology. PMID 29559171 DOI: 10.1016/J.Ygyno.2018.03.048  0.393
2018 Unger JM, Hershman DL, Till C, Tangen CM, Barlow WE, Ramsey SD, Goodman PJ, Thompson IM. Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial. Journal of the National Cancer Institute. PMID 29534197 DOI: 10.1093/Jnci/Djy035  0.361
2018 Buskwofie A, Huang Y, Tergas AI, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD. Impact of hospital volume on racial disparities and outcomes for endometrial cancer. Gynecologic Oncology. PMID 29506862 DOI: 10.1016/J.Ygyno.2018.02.019  0.383
2018 Gunther JE, Lim EA, Kim HK, Flexman M, Altoé M, Campbell JA, Hibshoosh H, Crew KD, Kalinsky K, Hershman DL, Hielscher AH. Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer. Radiology. 161041. PMID 29431574 DOI: 10.1148/Radiol.2018161041  0.392
2018 Chavez-MacGregor M, Unger JM, Moseley A, Ramsey SD, Hershman DL. Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials. Cancer. PMID 29370458 DOI: 10.1002/Cncr.31241  0.394
2018 Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL, Wong SF, Fisch MJ, Lynn Henry N, Albain KS. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). Journal of the National Cancer Institute. PMID 29361042 DOI: 10.1093/Jnci/Djx259  0.317
2018 Mukerji B, Baptiste C, Chen L, Tergas AI, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD. Racial disparities in young women with endometrial cancer. Gynecologic Oncology. PMID 29307452 DOI: 10.1016/J.Ygyno.2017.12.032  0.42
2018 Sucheston-Campbell LE, Clay-Gilmour AI, Barlow WE, Budd GT, Stram DO, Haiman CA, Sheng X, Yan L, Zirpoli G, Yao S, Jiang C, Owzar K, Hershman D, Albain KS, Hayes DF, et al. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci. Pharmacogenetics and Genomics. 28: 49-55. PMID 29278617 DOI: 10.1097/Fpc.0000000000000318  0.373
2018 Watabayashi K, Bell-Brown A, Egan K, Kreizenbeck KL, Lyman GH, Hershman DL, Bansal A, Barlow WE, Sullivan SD, Ramsey SD. Impact of clinic characteristics on the adoption of a guideline-based standing order algorithm and patient accrual in the pragmatic cluster-randomized trial SWOG S1415CD (NCT02728596). Journal of Clinical Oncology. 36: 60-60. DOI: 10.1200/Jco.2018.36.30_Suppl.60  0.306
2018 Egan K, Bell-Brown A, Kreizenbeck KL, Watabayashi K, Lyman GH, Hershman DL, Bansal A, Barlow WE, Sullivan SD, Ramsey SD. From A to Xeloda: Practical considerations for implementing a chemotherapy regimen ordering system intervention. Journal of Clinical Oncology. 36: 57-57. DOI: 10.1200/Jco.2018.36.30_Suppl.57  0.38
2018 Barger S, Sullivan SD, Lyman GH, Hershman DL, Bell-Brown A, Watabayashi K, Egan K, Kreizenbeck KL, Ciccarella A, Gorman M, Bott B, Walia G, Johnson J, Seigel C, Railey E, et al. The influence of patient engagement on the design and implementation of a clinical trial to improve cancer care delivery. Journal of Clinical Oncology. 36: 223-223. DOI: 10.1200/Jco.2018.36.30_Suppl.223  0.345
2018 Ligibel JA, Barry WT, Alfano CM, Hershman DL, Irwin ML, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins JO, Bernstein V, Stearns V, White JR, et al. The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.Tps598  0.459
2018 Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL. Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials. Journal of Clinical Oncology. 36: 6569-6569. DOI: 10.1200/Jco.2018.36.15_Suppl.6569  0.436
2018 Unger JM, Hershman DL, Fleury M, Vaidya R. Patient comorbid conditions and cancer clinical trial participation. Journal of Clinical Oncology. 36: 6540-6540. DOI: 10.1200/Jco.2018.36.15_Suppl.6540  0.349
2018 Quyyumi F, Accordino MK, Buono D, Neugut A, Hillyer G, Wright JD, Hershman DL. Factors associated with follow-up physician visits among women with early stage breast cancer. Journal of Clinical Oncology. 36: 6531-6531. DOI: 10.1200/Jco.2018.36.15_Suppl.6531  0.472
2018 Dowling RJ, Parulekar WR, Gelmon KA, Shepherd LE, Virk S, Ennis M, Mao F, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Rabaglio-Poretti M, et al. CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC). Journal of Clinical Oncology. 36: 557-557. DOI: 10.1200/Jco.2018.36.15_Suppl.557  0.358
2018 Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers TB, Doster JE, Zarwan C, Kruper L, Minasian LM, et al. Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812). Journal of Clinical Oncology. 36: 1550-1550. DOI: 10.1200/Jco.2018.36.15_Suppl.1550  0.412
2018 Kalinsky K, Onishi M, Yu J, Trivedi MS, Accordino MK, Crew KD, Hershman DL, Maurer MA, Silva J. Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer. Journal of Clinical Oncology. 36: 1058-1058. DOI: 10.1200/Jco.2018.36.15_Suppl.1058  0.304
2018 Neugut AI, Zhong X, Lebwohl B, Hillyer GC, Accordino MK, Wright JD, Kiran RP, Hershman DL. Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study: Therapeutic Advances in Gastroenterology. 11: 175628481876592. DOI: 10.1177/1756284818765920  0.382
2018 Huang Y, Buskwofie A, Ruiz MP, Tergas AI, Hou JY, Clair CS, Ananth C, Hershman D, Wright JD. Patient profile, patterns of care, and mortality among Asian and white women with uterine cancer Gynecologic Oncology. 149: 135. DOI: 10.1016/J.Ygyno.2018.04.311  0.386
2018 Selter J, Huang Y, Becht LG, Palmerola KL, Forman EJ, Williams Z, Ananth CV, Neugut A, Hershman DL, Wright J. Use of fertility preservation services in female reproductive-aged cancer patients Fertility and Sterility. 110. DOI: 10.1016/J.Fertnstert.2018.07.538  0.323
2017 Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, et al. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study. Journal of the National Cancer Institute. 109. PMID 29546345 DOI: 10.1093/Jnci/Djx098  0.42
2017 Freedman RA, Revette AC, Hershman DL, Silva K, Sporn NJ, Gagne JJ, Kouri EM, Keating NL. Understanding Breast Cancer Knowledge and Barriers to Treatment Adherence: A Qualitative Study Among Breast Cancer Survivors. Bioresearch Open Access. 6: 159-168. PMID 29282433 DOI: 10.1089/Biores.2017.0028  0.47
2017 Champer M, Huang Y, Hou JY, Tergas AI, Burke WM, Hillyer GC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence. Gynecologic Oncology. PMID 29153542 DOI: 10.1016/J.Ygyno.2017.11.008  0.441
2017 Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017746651. PMID 29136387 DOI: 10.1200/Jco.2017.74.6651  0.395
2017 Bercow AS, Chen L, Chatterjee S, Tergas AI, Hou JY, Burke WM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Cost of Care for the Initial Management of Ovarian Cancer. Obstetrics and Gynecology. PMID 29112648 DOI: 10.1097/Aog.0000000000002317  0.301
2017 Lee SM, Hershman DL, Miao J, Zhong X, Unger JM, Cheung YKK. Estimating global treatment toxicity burden from adverse-event data. Cancer. PMID 29112232 DOI: 10.1002/Cncr.31107  0.331
2017 Jones NL, Chen L, Chatterjee S, Tergas AI, Burke WM, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD. National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28953134 DOI: 10.1097/Igc.0000000000001132  0.36
2017 Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. Npj Breast Cancer. 3: 37. PMID 28948213 DOI: 10.1038/s41523-017-0040-8  0.322
2017 Ruiz MP, Huang Y, Hou JY, Tergas AI, Burke WM, Ananth CV, Neugut AI, Hershman DL, Wright JD. All-Cause Mortality in Young Women with Endometrial Cancer Receiving Progesterone Therapy. American Journal of Obstetrics and Gynecology. PMID 28844824 DOI: 10.1016/J.Ajog.2017.08.007  0.392
2017 Wright JD, Chen L, Hou JY, Burke WM, Tergas AI, Ananth CV, Neugut AI, Hershman DL. Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer. Obstetrics and Gynecology. PMID 28796677 DOI: 10.1097/Aog.0000000000002164  0.348
2017 Accordino MK, Wright JD, Vasan S, Neugut AI, Gross T, Hillyer GC, Hershman DL. Association between survival time with metastatic breast cancer and aggressive end-of-life care. Breast Cancer Research and Treatment. PMID 28752188 DOI: 10.1007/S10549-017-4420-4  0.439
2017 Margolis B, Chen L, Accordino MK, Hillyer GC, Hou JY, Tergas AI, Burke WM, Neugut AI, Ananth CV, Hershman DL, Wright JD. Trends in End of Life Care and Healthcare Spending in Women with Uterine Cancer. American Journal of Obstetrics and Gynecology. PMID 28709581 DOI: 10.1016/J.Ajog.2017.07.006  0.396
2017 Lee SM, Zhang Y, Minasian LM, Unger JM, Hershman DL. Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib. Cancer Investigation. 1-6. PMID 28692317 DOI: 10.1080/07357907.2017.1340479  0.32
2017 Bansal A, Sullivan SD, Hershman DL, Lyman GH, Barlow WE, McCune JS, Ramsey SD. A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. Journal of Comparative Effectiveness Research. PMID 28686055 DOI: 10.2217/Cer-2017-0005  0.455
2017 Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS. How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? Npj Breast Cancer. 3: 20. PMID 28649660 DOI: 10.1038/s41523-017-0021-y  0.362
2017 Wright JD, Chen L, Gabor L, Burke WM, Tergas AI, Hou JY, Ananth CV, Neugut AI, Hershman DL. Patterns of Specialty-Based Referral and Perioperative Outcomes for Women With Endometrial Cancer Undergoing Hysterectomy. Obstetrics and Gynecology. PMID 28594765 DOI: 10.1097/Aog.0000000000002100  0.4
2017 Lohmann AE, Liebman MF, Brien W, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, et al. Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. Breast Cancer Research and Treatment. PMID 28447237 DOI: 10.1007/S10549-017-4265-X  0.386
2017 Bian J, Chen B, Hershman DL, Marks N, Norris L, Schulz R, Bennett C. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017726273. PMID 28441110 DOI: 10.1200/Jco.2017.72.6273  0.365
2017 Kwan ML, Roh JM, Laurent CA, Lee J, Tang L, Hershman D, Kushi LH, Yao S. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes & Control : Ccc. PMID 28349440 DOI: 10.1007/S10552-017-0888-9  0.4
2017 Cham S, Huang Y, Tergas AI, Hou JY, Burke WM, Deutsch I, Ananth CV, Neugut AI, Hershman DL, Wright JD. Utility of radiation therapy for early-stage uterine papillary serous carcinoma. Gynecologic Oncology. PMID 28343693 DOI: 10.1016/J.Ygyno.2017.03.003  0.305
2017 Wright JD, Desai VB, Chen L, Burke WM, Tergas AI, Hou JY, Accordino M, Ananth CV, Neugut AI, Hershman DL. Utilization of Gynecologic Services in Women with Breast Cancer Receiving Hormonal Therapy. American Journal of Obstetrics and Gynecology. PMID 28341383 DOI: 10.1016/J.Ajog.2017.03.011  0.453
2017 Lim EA, Gunther JE, Kim HK, Flexman M, Hibshoosh H, Crew K, Taback B, Campbell J, Kalinsky K, Hielscher A, Hershman DL. Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. PMID 28190249 DOI: 10.1007/S10549-017-4150-7  0.449
2017 Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hershman DL. Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies. Cancer Investigation. 1-13. PMID 28165774 DOI: 10.1080/07357907.2016.1276186  0.311
2017 Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, Kushi LH. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. Journal of the National Cancer Institute. 109. PMID 27794123 DOI: 10.1093/Jnci/Djw206  0.435
2017 Kroenke C, Hershman DL, Adams S, Kwan ML, Kushi LH. Social support at diagnosis and noninitiation, discontinuation, and nonadherence to adjuvant hormonal therapy in the Pathways Study. Journal of Clinical Oncology. 35: 7-7. DOI: 10.1200/Jco.2017.35.5_Suppl.7  0.372
2017 Onishi M, Vasan S, Accordino MK, Hillyer G, Neugut AI, Wright JD, Hershman DL. Factors associated with neurokinin-1 receptor antagonist use among commercially insured cancer patients receiving highly emetogenic chemotherapy. Journal of Clinical Oncology. 35: 24-24. DOI: 10.1200/Jco.2017.35.5_Suppl.24  0.387
2017 Kalinsky K, Mundi PS, Chiuzan C, Accordino MK, Trivedi MS, Sparano JA, Oh SY, Tiersten A, O'Regan R, Esteva FJ, Jain S, Mayer IA, Forero A, Baer LN, Crew KD, ... Hershman DL, et al. A randomized phase II trial of fulvestrant with or without ribociclib after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with unresectable or metastatic hormone receptor positive, HER2 negative breast cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps1112  0.346
2017 Rowland JC, Hershman DL, Kalinsky K, Crew KD, Cheung YK, Lee SM. Differences in global toxicity burden among patients and care providers during initial chemotherapy for breast cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E21649  0.45
2017 Carlson JJ, Kim D, Guzauskas GF, Bennette CS, Hershman DL, Baker LH, Hendrix N, Basu A, Veenstra DL, Ramsey S. Impact of value of research analyses on SWOG’s clinical trial capsule scoring. Journal of Clinical Oncology. 35: e18311-e18311. DOI: 10.1200/Jco.2017.35.15_Suppl.E18311  0.312
2017 Greenlee H, Neugut AI, Shi Z, Hillyer G, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai W, Lamerato LE, Kushi LH, Hershman DL. Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study. Journal of Clinical Oncology. 35: e13097-e13097. DOI: 10.1200/Jco.2017.35.15_Suppl.E13097  0.454
2017 Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM, Klein EA, LeBlanc ML, Blanke CD, Goodman PJ, Minasian LM, Hershman DL. The scientific impact and value of large, NCI-sponsored randomized phase III cancer prevention trials. Journal of Clinical Oncology. 35: 1541-1541. DOI: 10.1200/Jco.2017.35.15_Suppl.1541  0.387
2017 Seidman AD, Regan MM, Hershman DL, Korde LA, Perlmutter J, Barlow WE, Rubinstein L, Fehrenbacher L, Beaver JA, Amiri-Kordestani L, Wedam SB, Smith ML, Rastogi P, Bordeleau L, Butler LP, et al. NCI Breast Cancer Steering Committee Working Group (WG) report on meaningful and appropriate endpoints for clinical trials (CT) in metastatic breast cancer (MBC). Journal of Clinical Oncology. 35: 1073-1073. DOI: 10.1200/Jco.2017.35.15_Suppl.1073  0.362
2017 Barzi A, Hershman DL, Till C, Lenz H, Hochster HS, Unger JM. Patterns of osteoporosis (OP) in survivors of colorectal cancer (CRC) enrolled on SWOG trials. Journal of Clinical Oncology. 35: 10056-10056. DOI: 10.1200/Jco.2017.35.15_Suppl.10056  0.347
2017 Leng S, Lentzsch S, Shen Y, Wright JD, Hershman D, Neugut AI. Use of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors Blood. 130: 2117-2117. DOI: 10.1182/Blood.V130.Suppl_1.2117.2117  0.338
2017 Henry N, Unger J, Schott A, Fehrenbacher L, Flynn P, Prow D, Sharer C, Lew D, Moseley A, Fisch M, Moinpour C, Hershman D, Wade J. Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202) Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-S5-06  0.398
2017 Altoe ML, Gunther JE, Lim E, Kim HK, Campbell J, Hibshoosh H, Crew K, Kalinsky K, Hershman DL, Hielscher AH. Baseline oxygen saturation comparison between pathologic complete responders and extensive residual cancer cases in response to neoadjuvant chemotherapy Proceedings of Spie. 10059. DOI: 10.1117/12.2251452  0.393
2017 Margolis B, Chen L, Tergas A, Hou J, Burke W, Hershman D, Wright J. Trends in end-of-life care and health care spending in women with uterine cancer Gynecologic Oncology. 145: 62. DOI: 10.1016/J.Ygyno.2017.03.150  0.328
2017 Ruiz MP, Huang Y, Hou JY, Tergas AI, Burke WM, Hershman D, Wright JD. Safety of progestational therapy in young women with endometrial cancer Gynecologic Oncology. 145: 40. DOI: 10.1016/J.Ygyno.2017.03.103  0.392
2016 Potkul RK, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, Smith BL, Wong L, Campbell DL, Einspahr DE, Anderson GL, Hershman D, Goodman GE, Brown PH, Meyskens FL, et al. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Npj Breast Cancer. 2: 16024. PMID 28721383 DOI: 10.1038/npjbcancer.2016.24  0.362
2016 Chen L, Jorge S, Burke WM, Tergas A, Hou J, Hu J, Neugut AI, Ananth C, Hershman DL. Utilization and effectiveness of extended-duration thromboprophylaxis after high-risk abdominopelvic cancer surgery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 62. PMID 28152776 DOI: 10.1200/Jco.2016.34.7_Suppl.62  0.388
2016 Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross CP, Hershman D, Ligibel J, Schmitz K, Li FY, Sanft T, Irwin ML. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity (Silver Spring, Md.). PMID 28026901 DOI: 10.1002/Oby.21729  0.373
2016 Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL. Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27986655 DOI: 10.1158/1055-9965.Epi-15-1336  0.387
2016 Hu JH, O'Malley P, Chughtai B, Isaacs A, Mao J, Wright JD, Hershman D, Sedrakyan A. Comparative Effectiveness of Cancer Control and Survival After Robot Assisted versus Open Radical Prostatectomy. The Journal of Urology. PMID 27720782 DOI: 10.1016/J.Juro.2016.09.115  0.339
2016 Yoon L, Clarke Hillyer G, Chen L, Hu JC, Neugut AI, Hershman DL, Wright JD. Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients. Cancer Investigation. 1-7. PMID 27624740 DOI: 10.1080/07357907.2016.1221078  0.316
2016 Cham S, Chen L, Burke WM, Hou JY, Tergas AI, Hu JC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Utilization and Outcomes of Sentinel Lymph Node Biopsy for Vulvar Cancer. Obstetrics and Gynecology. PMID 27607871 DOI: 10.1097/Aog.0000000000001648  0.34
2016 Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross C, Hershman D, Ligibel J, Schmitz K, Li FY, Sanft T, Irwin ML. Randomized Trial Of Exercise On Body Composition In Breast Cancer Survivors Taking Aromatase Inhibitors: 1285 Board #6 June 2, 8: 00 AM - 10: 00 AM. Medicine and Science in Sports and Exercise. 48: 334. PMID 27584324 DOI: 10.1249/01.Mss.0000486010.57056.60  0.389
2016 Unger JM, Till C, Thompson IM, Tangen CM, Goodman PJ, Wright JD, Barlow WE, Ramsey SD, Minasian LM, Hershman DL. Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial. Journal of the National Cancer Institute. 108. PMID 27565902 DOI: 10.1093/Jnci/Djw168  0.341
2016 Greenlee H, Odgen Gaffney A, Aycinena AC, Koch P, Contento I, Karmally W, Richardson JM, Shi Z, Lim E, Tsai WY, Santella RM, Blaner WS, Clugston RD, Cremers S, Pollak S, ... ... Hershman DL, et al. Long-term diet and biomarker changes after a short-term intervention among Hispanic breast cancer survivors: The ¡Cocinar Para Su Salud! randomized controlled trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27461049 DOI: 10.1158/1055-9965.Epi-15-1334  0.371
2016 Yang J, Neugut AI, Wright JD, Accordino M, Hershman DL. Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 27407167 DOI: 10.1200/Jop.2016.011742  0.413
2016 Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Hillyer GC, Chen L, Hershman DL. Axillary evaluation and lymphedema in women with ductal carcinoma in situ. Breast Cancer Research and Treatment. PMID 27365080 DOI: 10.1007/S10549-016-3890-0  0.442
2016 Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27325863 DOI: 10.1200/Jco.2015.66.2346  0.339
2016 Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Buono DL, Nathanson SD, Bovbjerg DH, Mandelblatt JS, Tsai WY, Jacobson JS, Hershman DL. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Research and Treatment. PMID 27287779 DOI: 10.1007/S10549-016-3855-3  0.507
2016 Neugut AI, Zhong X, Wright JD, Accordino M, Yang J, Hershman DL. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer. Jama Oncology. PMID 27281650 DOI: 10.1001/Jamaoncol.2016.1291  0.409
2016 Hershman DL, Unger JM. Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply. Jama Oncology. 2: 686-687. PMID 27244679 DOI: 10.1001/Jamaoncol.2016.0370  0.317
2016 Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Kushi LH, Hershman DL. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. Jama Oncology. PMID 27243607 DOI: 10.1001/Jamaoncol.2016.0685  0.487
2016 Hershman DL. Sticking to It: Improving Outcomes by Increasing Adherence Journal of Clinical Oncology. 34: 2440-2442. PMID 27217447 DOI: 10.1200/Jco.2016.67.7336  0.442
2016 Aycinena AC, Jennings KA, Gaffney AO, Koch PA, Contento IR, Gonzalez M, Guidon E, Karmally W, Hershman D, Greenlee H. ¡Cocinar Para Su Salud! Development of a Culturally Based Nutrition Education Curriculum for Hispanic Breast Cancer Survivors Using a Theory-Driven Procedural Model. Health Education & Behavior : the Official Publication of the Society For Public Health Education. PMID 27179286 DOI: 10.1177/1090198116642236  0.375
2016 Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hu JC, Hershman DL. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27161970 DOI: 10.1200/Jco.2016.66.6313  0.442
2016 Wright JD, Hou JY, Burke WM, Tergas AI, Chen L, Hu JC, Ananth CV, Neugut AI, Hershman DL. Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer. Obstetrics and Gynecology. PMID 27159764 DOI: 10.1097/Aog.0000000000001436  0.42
2016 Chatterjee S, Chen L, Tergas AI, Burke WM, Hou JY, Hu JC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer. Obstetrics and Gynecology. PMID 27159756 DOI: 10.1097/Aog.0000000000001404  0.427
2016 Greenlee H, Molmenti CL, Crew KD, Awad D, Kalinsky K, Brafman L, Fuentes D, Shi Z, Tsai WY, Neugut AI, Hershman DL. Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivors. Journal of Cancer Survivorship : Research and Practice. PMID 27100859 DOI: 10.1007/S11764-016-0541-8  0.319
2016 Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jacobson JS, Wright JD, Neugut AI. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Research and Treatment. PMID 27086286 DOI: 10.1007/S10549-016-3788-X  0.431
2016 Cui Z, Wright JD, Accordino MK, Buono D, Neugut AI, Hu JC, Hershman DL. Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients. Cancer Investigation. 1-8. PMID 27065211 DOI: 10.3109/07357907.2016.1166232  0.347
2016 Wright JD, Chen L, Jorge S, Burke WM, Tergas AI, Hou JY, Hu JC, Neugut AI, Ananth CV, Hershman DL. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery. Gynecologic Oncology. PMID 27032377 DOI: 10.1016/J.Ygyno.2016.03.023  0.4
2016 Greenlee H, Crew KD, Capodice J, Awad D, Buono D, Shi Z, Jeffres A, Wyse S, Whitman W, Trivedi MS, Kalinsky K, Hershman DL. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer. Breast Cancer Research and Treatment. PMID 27013473 DOI: 10.1007/S10549-016-3759-2  0.415
2016 Tergas AI, Neugut AI, Chen L, Burke WM, Hershman DL, Wright JD. Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis. Cancer Investigation. 1-11. PMID 26986809 DOI: 10.3109/07357907.2015.1131291  0.396
2016 Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty M, Arnone A, Hanley A, Stevens S, et al. Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics. 94: 719-28. PMID 26972644 DOI: 10.1016/J.Ijrobp.2015.12.012  0.368
2016 Unger JM, Barlow WE, Ramsey SD, LeBlanc M, Blanke CD, Hershman DL. The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials. Jama Oncology. PMID 26967260 DOI: 10.1001/Jamaoncol.2015.6487  0.348
2016 Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future Oncology (London, England). PMID 26952901 DOI: 10.2217/Fon-2015-0076  0.388
2016 John GM, Hershman DL, Falci L, Shi Z, Tsai WY, Greenlee H. Complementary and alternative medicine use among US cancer survivors. Journal of Cancer Survivorship : Research and Practice. PMID 26920872 DOI: 10.1007/S11764-016-0530-Y  0.379
2016 Zhong X, Lim EA, Hershman DL, Moinpour CM, Unger J, Lee SM, Zhong X, Lim EA, Hershman DL, Moinpour CM, Unger J, Lee SM. ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 26907453 DOI: 10.1200/Jop.2015.006106  0.311
2016 Wright JD, Chen L, Tergas AI, Accordino M, Ananth CV, Neugut AI, Hershman DL. Underuse of BRCA Testing in Patients with Breast and Ovarian Cancer. American Journal of Obstetrics and Gynecology. PMID 26875946 DOI: 10.1016/J.Ajog.2016.02.011  0.445
2016 Wright JD, Margolis B, Hou JY, Burke WM, Tergas AI, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL. Overuse of External Beam Radiotherapy for Stage I Endometrial Cancer. American Journal of Obstetrics and Gynecology. PMID 26875941 DOI: 10.1016/J.Ajog.2016.02.007  0.352
2016 Wright JD, Tergas AI, Hou JY, Burke WM, Huang Y, Hu JC, Hillyer GC, Ananth CV, Neugut AI, Hershman DL. Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors. Obstetrics and Gynecology. PMID 26855104 DOI: 10.1097/Aog.0000000000001293  0.36
2016 Wright JD, Burke WM, Tergas AI, Hou JY, Huang Y, Hu JC, Hillyer GC, Ananth CV, Neugut AI, Hershman DL. Comparative Effectiveness of Minimally Invasive Hysterectomy for Endometrial Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26834057 DOI: 10.1200/Jco.2015.65.3212  0.368
2016 Aycinena AC, Valdovinos C, Crew KD, Tsai WY, Mata JM, Sandoval R, Hershman D, Greenlee H. Barriers to Recruitment and Adherence in a Randomized Controlled Diet and Exercise Weight Loss Intervention Among Minority Breast Cancer Survivors. Journal of Immigrant and Minority Health / Center For Minority Public Health. PMID 26801931 DOI: 10.1007/S10903-015-0310-1  0.39
2016 Arem H, Sorkin M, Cartmel B, Fiellin M, Capozza S, Harrigan M, Ercolano E, Zhou Y, Sanft T, Gross C, Schmitz K, Neogi T, Hershman D, Ligibel J, Irwin ML. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study. Journal of Cancer Survivorship : Research and Practice. PMID 26782031 DOI: 10.1007/S11764-015-0511-6  0.356
2016 Jorge S, Hou JY, Tergas AI, Burke WM, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. Gynecologic Oncology. PMID 26768835 DOI: 10.1016/J.Ygyno.2016.01.002  0.337
2016 Hershman DL, Unger JM, Wright JD, Ramsey S, Till C, Tangen CM, Barlow WE, Blanke C, Thompson IM, Hussain M. Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer. Jama Oncology. 2: 453-61. PMID 26720308 DOI: 10.1001/Jamaoncol.2015.4655  0.334
2016 Gunther J, Lim E, Kim H, Altoe M, Refrice S, Brown M, Kalinsky K, Hershman D, Hielscher AH. 5-Month Monitoring of Tumor Response in Patients with Breast Cancer who undergo Neoadjuvent Therapy with Diffuse Optical Tomography Cancer. DOI: 10.1364/Cancer.2016.Jm4A.2  0.365
2016 Lee SM, Hershman DL, Rowland J, Aguilar S, Kalinsky K, Crew KD, Cheung YK. Comparison of physicians, nurses' and patients' assessment of overall symptom burden. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E18123  0.338
2016 Lim EA, Zhong X, Wright JD, Neugut AI, Fojo AT, Hu JC, Unger JM, Hershman DL. Diffusion of abiraterone use in prostate cancer patients. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E18062  0.33
2016 Albain KS, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, Smith BL, Wong L, Campbell D, Einspahr DE, Anderson GL, Hershman DL, Goodman GE, Brown P, Meyskens FL, et al. Randomized trial of medroxyprogesterone acetate for prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Journal of Clinical Oncology. 34: 547-547. DOI: 10.1200/Jco.2016.34.15_Suppl.547  0.488
2016 Sanft TB, Cartmel B, Harrigan M, Li F, Loftfield E, Playdon M, Zhou Y, Gross CP, Ligibel JA, Schmitz KH, Hershman DL, Pusztai L, Irwin ML. Impact of weight loss and exercise on VEGF levels in breast cancer survivors. Journal of Clinical Oncology. 34: 10103-10103. DOI: 10.1200/Jco.2016.34.15_Suppl.10103  0.387
2016 Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, Kushi LH. Body mass index, lifestyle factors, and taxane-induced neuropathy in women with breast cancer: The Pathways study. Journal of Clinical Oncology. 34: 10002-10002. DOI: 10.1200/Jco.2016.34.15_Suppl.10002  0.361
2016 Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger JM. Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants in SWOG clinical trials. Journal of Clinical Oncology. 34: 10001-10001. DOI: 10.1200/Jco.2016.34.15_Suppl.10001  0.314
2016 Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Livingston RB, Hortobagyi GN, Gralow JR, et al. Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221 Cancer Research. 76: 3413-3413. DOI: 10.1158/1538-7445.Am2016-3413  0.46
2016 Wright JD, Jorge S, Burke WM, Hou JY, Tergas AI, Huang Y, Hershman D. Use of whole pelvic radiotherapy for high-intermediate risk endometrial cancer Gynecologic Oncology. 141: 42. DOI: 10.1016/J.Ygyno.2016.04.130  0.381
2016 Hu J, Chughtai B, O'Malley P, Isaacs A, Wright J, Hershman D, Sedrakyan A. Comparative effectiveness of cancer control and survival after robotic assisted versus open radical prostatectomy International Journal of Surgery. 36. DOI: 10.1016/J.Ijsu.2016.11.065  0.321
2016 Majithia N, Temkin SM, Ruddy KJ, Beutler AS, Hershman DL, Loprinzi CL. National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons Supportive Care in Cancer. 24: 1439-1447. DOI: 10.1007/S00520-015-3063-4  0.412
2015 Canin B, Freund KM, Ganz PA, Hershman DL, Paskett ED. Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9-10 October 2014. Npj Breast Cancer. 1: 15013. PMID 28721369 DOI: 10.1038/npjbcancer.2015.13  0.329
2015 Crew KD, Xiao T, Thomas PS, Terry MB, Maurer M, Kalinsky K, Feldman S, Brafman L, Refice SR, Hershman DL. Safety, Feasibility, and Biomarker Effects of High-Dose Vitamin D Supplementation Among Women at High Risk for Breast Cancer. International Journal of Food Science, Nutrition and Dietetics. 2015: 1-16. PMID 28480224 DOI: 10.19070/2326-3350-Si01001  0.355
2015 Chen EI, Crew KD, Trivedi M, Awad D, Maurer M, Kalinsky K, Koller A, Patel P, Kim Kim J, Hershman DL. Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology. Plos One. 10: e0145816. PMID 26710119 DOI: 10.1371/Journal.Pone.0145816  0.397
2015 Majithia N, Temkin SM, Ruddy KJ, Beutler AS, Hershman DL, Loprinzi CL. National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 24: 1439-47. PMID 26686859 DOI: 10.1007/s00520-015-3063-4  0.303
2015 Wright JD, Huang Y, Burke WM, Tergas AI, Hou JY, Hu JC, Neugut AI, Ananth CV, Hershman DL. Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstetrics and Gynecology. PMID 26646130 DOI: 10.1097/Aog.0000000000001194  0.425
2015 Wright JD, Jorge S, Tergas AI, Hou JY, Burke WM, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL. Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer. Obstetrics and Gynecology. PMID 26646128 DOI: 10.1097/Aog.0000000000001181  0.424
2015 Bernard-Davila B, Aycinena AC, Richardson J, Gaffney AO, Koch P, Contento I, Molmenti CS, Alvarez M, Hershman D, Greenlee H. Barriers and facilitators to recruitment to a culturally-based dietary intervention among urban Hispanic breast cancer survivors. Journal of Racial and Ethnic Health Disparities. 2: 244-255. PMID 26557471 DOI: 10.1007/S40615-014-0076-5  0.411
2015 Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL. Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study. Jama Oncology. 1-3. PMID 26468994 DOI: 10.1001/Jamaoncol.2015.3924  0.392
2015 Ligibel JA, Alfano CM, Hershman D, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens W, Minasian LM, O'Rourke MA, et al. Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26324364 DOI: 10.1200/Jco.2015.63.1440  0.416
2015 Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC. Population-based assessment of determining predictors for quality of prostate cancer surveillance. Cancer. PMID 26307939 DOI: 10.1002/Cncr.29574  0.341
2015 Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D, Giordano SH, Goldstein M, Guadagnolo BA, Kosty M, Hopkins S, Yu JB, Arnone A, Hanley A, Stevens S, ... Hershman DL, et al. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26304878 DOI: 10.1200/Jco.2015.61.1558  0.423
2015 Wright JD, Chen L, Tergas AI, Burke WM, Hou JY, Neugut AI, Ananth CV, Hershman DL. Population-level trends in relative survival for cervical cancer. American Journal of Obstetrics and Gynecology. PMID 26210758 DOI: 10.1016/J.Ajog.2015.07.012  0.387
2015 Wright JD, Tergas AI, Cui R, Burke WM, Hou JY, Ananth CV, Chen L, Richards C, Neugut AI, Hershman DL. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy. Jama Oncology. 1: 69-77. PMID 26182307 DOI: 10.1001/Jamaoncol.2014.206  0.304
2015 Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, Hershman DL. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Jama Oncology. 1: 323-32. PMID 26181180 DOI: 10.1001/Jamaoncol.2015.0389  0.326
2015 Wright JD, Huang Y, Ananth CV, Tergas AI, Duffy C, Deutsch I, Burke WM, Hou JY, Neugut AI, Hershman DL. Influence of Treatment Center and Hospital Volume on Survival for Locally Advanced Cervical Cancer. Gynecologic Oncology. PMID 26177552 DOI: 10.1016/J.Ygyno.2015.07.015  0.359
2015 Greenlee H, Crew KD, Capodice J, Awad D, Jeffres A, Unger JM, Lew DL, Hansen LK, Meyskens FL, Wade JL, Hershman DL. Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients. Journal of Acupuncture and Meridian Studies. 8: 152-8. PMID 26100070 DOI: 10.1016/J.Jams.2015.03.006  0.379
2015 Wright JD, Tergas AI, Ananth CV, Burke WM, Hou JY, Chen L, Neugut AI, Richards CA, Hershman DL. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Cancer Investigation. PMID 26068056 DOI: 10.3109/07357907.2015.1047506  0.313
2015 Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D. Erratum. Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer. Journal of the National Cancer Institute. Monographs. 2015: 98. PMID 26063898 DOI: 10.1093/jncimonographs/lgv024  0.31
2015 Hershman DL, Ganz PA. Quality of care, including survivorship care plans Advances in Experimental Medicine and Biology. 862: 255-269. PMID 26059941 DOI: 10.1007/978-3-319-16366-6_17  0.403
2015 Hershman DL, Loprinzi C, Schneider BP. Symptoms: Aromatase inhibitor induced arthralgias Advances in Experimental Medicine and Biology. 862: 89-100. PMID 26059931 DOI: 10.1007/978-3-319-16366-6_7  0.468
2015 Schneider BP, Hershman DL, Loprinzi C. Symptoms: Chemotherapy-induced peripheral neuropathy Advances in Experimental Medicine and Biology. 862: 77-87. PMID 26059930 DOI: 10.1007/978-3-319-16366-6_6  0.388
2015 Dinkelspiel HE, Champer M, Hou J, Tergas A, Burke WM, Huang Y, Neugut AI, Ananth CV, Hershman DL, Wright JD. Long-term mortality among women with epithelial ovarian cancer. Gynecologic Oncology. PMID 26050923 DOI: 10.1016/J.Ygyno.2015.06.005  0.401
2015 Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, Neugut AI, Ananth CV, Hershman DL. Trends in relative survival for ovarian cancer from 1975 to 2011. Obstetrics and Gynecology. 125: 1345-52. PMID 26000505 DOI: 10.1097/Aog.0000000000000854  0.405
2015 Feathers A, Aycinena AC, Lovasi GS, Rundle A, Gaffney AO, Richardson J, Hershman D, Koch P, Contento I, Greenlee H. Food environments are relevant to recruitment and adherence in dietary modification trials. Nutrition Research (New York, N.Y.). 35: 480-8. PMID 25981966 DOI: 10.1016/J.Nutres.2015.04.007  0.342
2015 Patankar S, Burke WM, Hou JY, Tergas AI, Huang Y, Ananth CV, Neugut AI, Hershman DL, Wright JD. Risk stratification and outcomes of women undergoing surgery for ovarian cancer. Gynecologic Oncology. 138: 62-9. PMID 25976399 DOI: 10.1016/J.Ygyno.2015.04.037  0.433
2015 Greenlee H, Gaffney AO, Aycinena AC, Koch P, Contento I, Karmally W, Richardson JM, Lim E, Tsai WY, Crew K, Maurer M, Kalinsky K, Hershman DL. ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. Journal of the Academy of Nutrition and Dietetics. 115: S42-S56.e3. PMID 25911520 DOI: 10.1016/J.Jand.2015.02.027  0.399
2015 Reimers LL, Sivasubramanian PS, Hershman D, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M, Crew KD. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ. The Breast Journal. 21: 377-86. PMID 25879521 DOI: 10.1111/Tbj.12418  0.433
2015 Delgado-Cruzata L, Zhang W, McDonald JA, Tsai WY, Valdovinos C, Falci L, Wang Q, Crew KD, Santella RM, Hershman DL, Greenlee H. Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivors. The Journal of Nutrition. 145: 783-90. PMID 25833781 DOI: 10.3945/Jn.114.202853  0.314
2015 Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL, Habel LA, Caan BJ, Gomez SL. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. American Journal of Public Health. 105: 938-46. PMID 25790426 DOI: 10.2105/Ajph.2014.302406  0.381
2015 Goodwin PJ, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee SD, Chalchal HI, et al. Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. Journal of the National Cancer Institute. 107. PMID 25740979 DOI: 10.1093/Jnci/Djv006  0.381
2015 Dinkelspiel HE, Tergas AI, Zimmerman LA, Burke WM, Hou JY, Chen L, Hillyer G, Neugut AI, Hershman DL, Wright JD. Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer. Gynecologic Oncology. 137: 203-9. PMID 25703674 DOI: 10.1016/J.Ygyno.2015.02.013  0.402
2015 Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1053-9. PMID 25691670 DOI: 10.1200/Jco.2014.58.3062  0.406
2015 Wright JD, Tergas AI, Ananth CV, Burke WM, Chen L, Neugut AI, Richards CA, Hershman DL. Relationship between surgical oncologic outcomes and publically reported hospital quality and satisfaction measures. Journal of the National Cancer Institute. 107. PMID 25618899 DOI: 10.1093/Jnci/Dju409  0.333
2015 Accordino MK, Wright JD, Buono D, Neugut AI, Hershman DL. Trends in use and safety of image-guided transthoracic needle biopsies in patients with cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 11: e351-9. PMID 25604594 DOI: 10.1200/Jop.2014.001891  0.369
2015 Greenlee H, Gaffney AO, Aycinena AC, Koch P, Contento I, Karmally W, Richardson JM, Lim E, Tsai WY, Crew K, Maurer M, Kalinsky K, Hershman DL. ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. Journal of the Academy of Nutrition and Dietetics. 115: 709-723.e3. PMID 25578926 DOI: 10.1016/J.Jand.2014.11.002  0.399
2015 Patankar SS, Tergas AI, Deutsch I, Burke WM, Hou JY, Ananth CV, Huang Y, Neugut AI, Hershman DL, Wright JD. High versus low-dose rate brachytherapy for cervical cancer. Gynecologic Oncology. 136: 534-41. PMID 25575481 DOI: 10.1016/J.Ygyno.2014.12.038  0.379
2015 Dessources K, Hou JY, Tergas AI, Burke WM, Ananth CV, Prendergast E, Chen L, Neugut AI, Hershman DL, Wright JD. Factors associated with 30-day hospital readmission after hysterectomy. Obstetrics and Gynecology. 125: 461-70. PMID 25569007 DOI: 10.1097/Aog.0000000000000623  0.404
2015 Unger JM, Hershman DL, Martin D, Etzioni RB, Barlow WE, LeBlanc M, Ramsey SR. The diffusion of docetaxel in patients with metastatic prostate cancer. Journal of the National Cancer Institute. 107. PMID 25540245 DOI: 10.1093/Jnci/Dju412  0.427
2015 Hershman DL. Perfecting breast-cancer treatment - Incremental gains and musculoskeletal pains New England Journal of Medicine. 372: 477-478. PMID 25495491 DOI: 10.1056/Nejme1413164  0.476
2015 Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1104-11. PMID 25452437 DOI: 10.1200/Jco.2014.57.1547  0.439
2015 Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes & Control : Ccc. 26: 187-203. PMID 25421379 DOI: 10.1007/S10552-014-0497-9  0.319
2015 Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, ... ... Hershman DL, et al. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association. 28: 272-82. PMID 24646362 DOI: 10.1111/Jhn.12229  0.424
2015 Awad D, Greenlee H, Crew KD, Buono D, Capodice J, Kalinsky K, Maurer MA, Hershman DL. Randomized sham controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy. Journal of Clinical Oncology. 33: e20738-e20738. DOI: 10.1200/Jco.2015.33.15_Suppl.E20738  0.382
2015 Lee SM, Lim E, Hershman DL, Unger JM, Zhong X. Symptom clusters in patients with advanced prostate cancer. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E20647  0.32
2015 Trivedi MS, Chen EI, Awad D, Koller A, Patel P, Kalinsky K, Maurer MA, Crew KD, Hershman DL. Identifying predictors of taxane-induced peripheral neuropathy using shotgun proteomics technology. Journal of Clinical Oncology. 33: 9607-9607. DOI: 10.1200/Jco.2015.33.15_Suppl.9607  0.394
2015 Greenlee H, Lew D, Hershman DL, Pierce JP, Hansen LK, Newman VA, Korner J, Sayegh A, Fehrenbacher L, Lo SS, Klemp JR, Rinn K, Robertson JM, Unger JM, Gralow J, et al. Phase II feasibility study of a physical activity and dietary change weight loss intervention in a subset analysis of breast cancer survivors (SWOG S1008). Journal of Clinical Oncology. 33: 9572-9572. DOI: 10.1200/Jco.2015.33.15_Suppl.9572  0.363
2015 Coromilas EJ, Wright JD, Huang Y, Feldman SM, Neugut AI, Chen L, Hershman DL. The influence of hospital and surgeon factors on the prevalence of axillary evaluation in ductal carcinoma in situ. Journal of Clinical Oncology. 33: 6529-6529. DOI: 10.1200/Jco.2015.33.15_Suppl.6529  0.335
2015 Gralow J, Barlow WE, Paterson AHG, Lew D, Stopeck A, Hayes DF, Hershman DL, Schubert M, Clemons MJ, Poznak CHV, Dees EC, Ingle JN, Falkson CI, Elias AD, Messino MJ, et al. Phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: SWOG/Alliance/ECOG-ACRIN/NCIC Clinical Trials Group/NRG Oncology study S0307. Journal of Clinical Oncology. 33: 503-503. DOI: 10.1200/Jco.2015.33.15_Suppl.503  0.447
2015 Hershman DL, Unger JM, Wright JD, Ramsey SD, Till C, Tangen CM, Barlow WE, Blanke CD, Thompson IM, Hussain M. Long-term consequences of intermittent and continuous androgen deprivation in older patients with metastatic prostate cancer. Journal of Clinical Oncology. 33: 5008-5008. DOI: 10.1200/Jco.2015.33.15_Suppl.5008  0.338
2015 Trivedi MS, Reimers L, Infante K, Hershman DL, Maurer M, Kalinsky K, Aguilar S, Sandoval R, Alvarez MC, Kukafka R, Crew KD. Abstract PR01: Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women Cancer Prevention Research. 8. DOI: 10.1158/1940-6215.Prev-14-Pr01  0.46
2015 Greenlee H, Unger J, LeBlanc M, Hershman DL. Abstract A44: Association between BMI at treatment initiation and cancer survival across multiple SWOG trials Cancer Prevention Research. 8. DOI: 10.1158/1940-6215.Prev-14-A44  0.439
2015 Adelson KB, Ramaswamy B, Sparano JA, Christos PJ, Wright JJ, Raptis G, Villalona MC, Ma CX, Hershman D, Baar J, Klein P, Cigler T, Budd GT, Novik Y, Tan AR, et al. Abstract S6-03: Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York cancer consortium trial Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S6-03  0.4
2015 Kalinsky K, Hibshoosh H, Zheng T, Crew KD, Refice S, Feldman S, Taback B, Connolly E, Maurer M, Hershman DL. Abstract P6-12-07: Discordance in cyclin D1 changes after metformin exposure by different protein expression methods: Results from a "Window of Opportunity" trial Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-12-07  0.334
2015 Baer L, Crew KD, Awad D, Kalinsky K, Maurer M, Hershman DL. Abstract P5-15-03: Baseline joint pain predicts severity of subsequent joint symptoms in women initiating aromatase inhibitors for early stage breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P5-15-03  0.389
2015 Lim EA, Gunther JE, Flexman M, Kim HK, Hibshoosh H, Kalinsky K, Crew K, Maurer M, Feldman S, Taback B, Ananthakrishnan P, Chen M, Refice S, Hielscher A, Hershman DL. Abstract P5-01-05: Early optical tomography changes correlate with residual cancer burden scores in women receiving neoadjuvant chemotherapy Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P5-01-05  0.362
2015 Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Abstract P4-14-03: Household net worth is associated with racial disparities in hormonal therapy adherence among women with early stage breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-14-03  0.458
2015 Thomas PS, Terry MB, Guo X, Zhao B, Ha R, Namburi S, Xiao T, Hershman D, Refice S, Crew KD. Abstract P1-01-08: Changes in breast density with mammography and breast MRI among high-risk postmenopausal women Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-01-08  0.418
2015 Kalinsky K, Mundi P, Hershman DL, Connolly E, Crew KD, Hibshoosh H, Calfiano A, Maurer M. Abstract OT1-1-08: Master regulator (MR)-directed therapy in residual breast cancer patient derived xenografts (PDXs) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Ot1-1-08  0.399
2015 Sucheston-Campbell L, Clay A, Barlow WE, Budd GT, Stram D, Haiman C, Yan L, Zirpoli G, Yao S, Hershman D, Albain KS, Hayes DF, Moore H, Hobday TJ, Stewart JA, et al. Abstract 5489: A genome-wide association study identifies novel loci associated with taxane-related sensory neuropathy in breast cancer patients enrolled in a cooperative group clinical trial (SWOG S0221) Cancer Research. 75: 5489-5489. DOI: 10.1158/1538-7445.Am2015-5489  0.413
2015 Gunther JE, Lim E, Kim HK, Brown M, Refice S, Kalinsky K, Hershman D, Hielscher AH. Dynamic diffuse optical tomography for assessing changes of breast tumors during neoadjuvant chemotherapy Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9319. DOI: 10.1117/12.2079435  0.318
2015 Wright J, Chen L, Ananth C, Tergas A, Hou J, Burke W, Neugut A, Hershman D. Secular trends in relative survival for ovarian cancer Gynecologic Oncology. 137: 112. DOI: 10.1016/J.Ygyno.2015.01.278  0.399
2015 Tergas A, Chen L, Ananth C, Hou J, Burke W, Neugut A, Hershman D, Wright J. Population-level survival trends for uterine cancer Gynecologic Oncology. 137: 94. DOI: 10.1016/J.Ygyno.2015.01.232  0.429
2015 Patankar SS, Tergas AI, Burke WM, Hou JY, Ananth C, Huang Y, Neugut A, Hershman D, Wright JD. High- versus low-dose rate brachytherapy for locally advanced cervical cancer Gynecologic Oncology. 137: 29. DOI: 10.1016/J.Ygyno.2015.01.066  0.323
2014 Blanco C, Markowitz JC, Hershman DL, Levenson JA, Wang S, Grann VR. A Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer. American Journal of Psychotherapy. 68: 489-95. PMID 26453348 DOI: 10.1176/Appi.Psychotherapy.2014.68.4.489  0.41
2014 Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. Journal of the National Cancer Institute. Monographs. 2014: 346-58. PMID 25749602 DOI: 10.1093/Jncimonographs/Lgu041  0.444
2014 Kwan ML, Lo JC, Tang L, Laurent CA, Roh JM, Chandra M, Hahn TE, Hong CC, Sucheston-Campbell L, Hershman DL, Quesenberry CP, Ambrosone CB, Kushi LH, Yao S. Bone health history in breast cancer patients on aromatase inhibitors. Plos One. 9: e111477. PMID 25354083 DOI: 10.1371/Journal.Pone.0111477  0.328
2014 Hershman DL, Tsui J, Meyer J, Glied S, Hillyer GC, Wright JD, Neugut AI. The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. Journal of the National Cancer Institute. 106. PMID 25349080 DOI: 10.1093/Jnci/Dju319  0.347
2014 Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM, Jones LW, Kakarala M, Ness KK, Merrill JK, Wollins DS, et al. American Society of Clinical Oncology position statement on obesity and cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3568-74. PMID 25273035 DOI: 10.1200/JCO.2014.58.4680  0.38
2014 Kalinsky K, Lim EA, Andreopoulou E, Desai AM, Jin Z, Tu Y, Hibshoosh H, Wang A, Greenlee H, Crew KD, Maurer M, Sparano JA, Hershman DL. Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer. Cancer Investigation. 32: 439-44. PMID 25254601 DOI: 10.3109/07357907.2014.958232  0.456
2014 Wright JD, Hershman DL. Measure for measure: the cost of improving quality. Journal of the National Cancer Institute. 106. PMID 25217778 DOI: 10.1093/Jnci/Dju266  0.435
2014 Hershman DL, Wright JD. Reply to A. Kolacevski et al. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 25139802 DOI: 10.1200/Jop.2014.001555  0.329
2014 Accordino MK, Neugut AI, Hershman DL. Cardiac effects of anticancer therapy in the elderly Journal of Clinical Oncology. 32: 2654-2661. PMID 25071122 DOI: 10.1200/Jco.2013.55.0459  0.379
2014 Tu Y, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, Negassa A, Montgomery LL, Wiechmann LS, Alpaugh RK, Huang M, et al. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Research and Treatment. 146: 145-52. PMID 24903226 DOI: 10.1007/S10549-014-3008-5  0.408
2014 Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Hershman DL. Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer (Tokyo, Japan). 21: 780-5. PMID 24902664 DOI: 10.1007/S12282-014-0543-1  0.464
2014 Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, Lee M, Sherman KJ, Ambrosone CB, Hershman DL, Neugut AI, Kushi LH. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. Bmc Cancer. 14: 382. PMID 24884705 DOI: 10.1186/1471-2407-14-382  0.37
2014 George EM, Tergas AI, Ananth CV, Burke WM, Lewin SN, Prendergast E, Neugut AI, Hershman DL, Wright JD. Safety and tolerance of radical hysterectomy for cervical cancer in the elderly. Gynecologic Oncology. 134: 36-41. PMID 24768851 DOI: 10.1016/J.Ygyno.2014.04.010  0.4
2014 Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1941-67. PMID 24733808 DOI: 10.1200/Jco.2013.54.0914  0.364
2014 Goss PE, Hershman DL, Cheung AM, Ingle JN, Khosla S, Stearns V, Chalchal H, Rowland K, Muss HB, Linden HM, Scher J, Pritchard KI, Elliott CR, Badovinac-Crnjevic T, St Louis J, et al. Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial. The Lancet. Oncology. 15: 474-82. PMID 24636210 DOI: 10.1016/S1470-2045(14)70035-X  0.422
2014 Unger JM, Barlow WE, Martin DP, Ramsey SD, Leblanc M, Etzioni R, Hershman DL. Comparison of survival outcomes among cancer patients treated in and out of clinical trials. Journal of the National Cancer Institute. 106: dju002. PMID 24627276 DOI: 10.1093/Jnci/Dju002  0.407
2014 Kalinsky K, Crew KD, Refice S, Xiao T, Wang A, Feldman SM, Taback B, Ahmad A, Cremers S, Hibshoosh H, Maurer M, Hershman DL. Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer. Cancer Investigation. 32: 150-7. PMID 24605899 DOI: 10.3109/07357907.2014.889706  0.384
2014 Smith CB, Kale M, Mhango G, Neugut AI, Hershman DL, Mandeli JP, Wisnivesky JP. Comparative outcomes of elderly stage I lung cancer patients treated with segmentectomy via video-assisted thoracoscopic surgery versus open resection. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 383-9. PMID 24495998 DOI: 10.1097/Jto.0000000000000083  0.352
2014 Wright JD, Ananth CV, Tsui J, Glied SA, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer. Cancer. 120: 1246-54. PMID 24443159 DOI: 10.1002/Cncr.28508  0.435
2014 Spencer BA, Shim JJ, Hershman DL, Zacharia BE, Lim EA, Benson MC, Neugut AI. Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 1549-55. PMID 24429841 DOI: 10.1007/S00520-013-2112-0  0.34
2014 Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. Journal of Neurosurgery. 120: 300-8. PMID 24286142 DOI: 10.3171/2013.10.Jns13113  0.328
2014 Yao S, Sucheston LE, Zhao H, Barlow WE, Zirpoli G, Liu S, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, et al. Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer. The Pharmacogenomics Journal. 14: 241-7. PMID 23999597 DOI: 10.1038/Tpj.2013.32  0.406
2014 Gunther J, Lim E, Kim HK, Flexman M, Refice S, Brown M, Kalinsky K, Hershman D, Hielscher A. Chemotherapy Monitoring of Breast Cancer Patients with a Dual-Breast Dynamic Optical Tomography System Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2014.Bw4B.4  0.395
2014 Hershman DL, Lacchetti C, Loprinzi CL. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline summary Journal of Oncology Practice. 10: e421-e424. DOI: 10.1200/Jop.2014.001776  0.334
2014 Kalinsky K, Chi D, Lee SM, Adelson KB, Crew KD, Chuang E, Makower D, Hershman DL, Califano A, Silva J, Maurer MA. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer. Journal of Clinical Oncology. 32: TPS666-TPS666. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps666  0.422
2014 Gucalp A, Morris PG, Zhou XK, Giri DD, Iyengar NM, Crew KD, Hershman DL, Garber JE, Nangia JR, Cook ED, Vornik L, Dunn BK, Heckman-Stoddard BM, Foster K, Brown P, et al. A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps1615  0.393
2014 Hershman DL, Unger JM, Crew KD, Dakhil SR, Awad D, Greenlee H, Minasian LM, Hansen L, Lew D, Gralow J, Wade JL, Meyskens FL, Moinpour C. Omega-3 fatty acids for aromatase inhibitor–induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927). Journal of Clinical Oncology. 32: 9532-9532. DOI: 10.1200/Jco.2014.32.15_Suppl.9532  0.406
2014 Accordino MK, Wright JD, Shim JJ, Neugut AI, Hillyer G, Hershman DL. Trends and safety of image-guided percutaneous pleural biopsies in cancer patients. Journal of Clinical Oncology. 32: 6608-6608. DOI: 10.1200/Jco.2014.32.15_Suppl.6608  0.357
2014 Lee SM, Cheung YK, Hershman DL. Looking beyond the first cycle in phase I cancer clinical trials. Journal of Clinical Oncology. 32: 6587-6587. DOI: 10.1200/Jco.2014.32.15_Suppl.6587  0.345
2014 Tergas AI, Neugut AI, Chen L, Lewin SN, Burke WM, Hershman DL, Wright JD. Prolonged radiation duration in women with cervical cancer: A population-based analysis of associated factors and impact on survival. Journal of Clinical Oncology. 32: 6518-6518. DOI: 10.1200/Jco.2014.32.15_Suppl.6518  0.449
2014 Tu Y, Hershman DL, Pellegrino CM, Andreopoulou E, Makower D, Fineberg S, Bhalla KN, Kalinsky K, Fehn K, Huang M, Alpaugh RK, Sparano JA. Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Journal of Clinical Oncology. 32: 598-598. DOI: 10.1200/Jco.2014.32.15_Suppl.598  0.354
2014 Gralow J, Barlow WE, Paterson AHG, Lew D, Stopeck A, Hayes DF, Hershman DL, Schubert M, Clemons M, Poznak CHV, Dees EC, Ingle JN, Falkson CI, Elias AD, Messino MJ, et al. SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery. Journal of Clinical Oncology. 32: 558-558. DOI: 10.1200/Jco.2014.32.15_Suppl.558  0.452
2014 Liebman MF, Brien W, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee S, et al. Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl). Journal of Clinical Oncology. 32: 542-542. DOI: 10.1200/Jco.2014.32.15_Suppl.542  0.334
2014 Sivasubramanian PS, Crew KD, Kalinsky K, Hershman DL, Maurer MA, Greenlee H, Reimers LL, Terry MB. Correlation between risk benefit index and uptake of breast cancer chemoprevention. Journal of Clinical Oncology. 32: 1568-1568. DOI: 10.1200/Jco.2014.32.15_Suppl.1568  0.452
2014 Aycinena AC, Gaffney AO, Koch P, Contento I, Richardson J, Crew K, Terry MB, Hershman DL, Greenlee H, Tehranifar P. Abstract B04: Development and comparison of 12-week and 4-week dietary interventions among Hispanic breast cancer survivors Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B04  0.385
2014 Kushi LH, Kwan ML, Ergas IJ, Laurent CA, Munneke JR, Roh JM, Greenlee H, Hong C, Keegan TH, Hershman DL, Kutner SE, Lee MM, Mandelblatt J, Neugut AI, Reynolds P, et al. Abstract 4127: A prospective study of breast cancer prognosis in Kaiser Permanente Northern California: Cohort description and initial findings from the Pathways Study Cancer Research. 74: 4127-4127. DOI: 10.1158/1538-7445.Am2014-4127  0.485
2014 Kwan ML, Lo JC, Tang L, Laurent C, Roh JM, Chandra M, Hahn TE, Hong C, Sucheston-Campbell L, Hershman DL, Caan BJ, Quesenberry CP, Sternfeld B, Ambrosone CB, Kushi LH, et al. Abstract 2162: Prior bone health history in breast cancer patients on aromatase inhibitors Cancer Research. 74: 2162-2162. DOI: 10.1158/1538-7445.Am2014-2162  0.378
2014 Tang L, Kwan ML, Yao S, Roh JM, Laurent CA, Hershman DL, Kumar S, Wilding GE, Ambrosone CB, Kushi LH. Abstract 1266: Racial differences in the association of cruciferous vegetable intake with breast cancer hormone receptor status and tumor subtype Cancer Research. 74: 1266-1266. DOI: 10.1158/1538-7445.Am2014-1266  0.435
2014 Wright JD, Neugut A, Tergas AI, Lewin SN, Burke WM, Lu YS, Herzog TJ, Hershman D. Surveillance testing in women following a diagnosis of early-stage endometrial cancer Gynecologic Oncology. 133: 201-202. DOI: 10.1016/J.Ygyno.2014.03.538  0.387
2013 Mahany EB, Hershman DL, Sauer MV, Choi JM. Pregnancy despite ovarian insufficiency in a patient with breast cancer. Reproductive Medicine and Biology. 12: 35-38. PMID 29699128 DOI: 10.1007/S12522-012-0133-X  0.479
2013 Kalinsky K, Hershman DL. Room for improvement in breast cancer clinical trial design: Taking advantage of the preoperative setting Journal of Comparative Effectiveness Research. 2: 393-403. PMID 24236681 DOI: 10.2217/Cer.13.35  0.382
2013 Wright JD, Hassan K, Ananth CV, Herzog TJ, Lewin SN, Burke WM, Lu YS, Neugut AI, Hershman DL. Use of guideline-based antibiotic prophylaxis in women undergoing gynecologic surgery. Obstetrics and Gynecology. 122: 1145-53. PMID 24201674 DOI: 10.1097/Aog.0B013E3182A8A36A  0.304
2013 Andreopoulou E, Vigoda IS, Valero V, Hershman DL, Raptis G, Vahdat LT, Han HS, Wright JJ, Pellegrino CM, Cristofanilli M, Alvarez RH, Fehn K, Fineberg S, Sparano JA. Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma. Breast Cancer Research and Treatment. 141: 429-35. PMID 24068539 DOI: 10.1007/S10549-013-2704-X  0.401
2013 Flexman ML, Kim HK, Gunther JE, Lim EA, Alvarez MC, Desperito E, Kalinsky K, Hershman DL, Hielscher AH. Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography. Journal of Biomedical Optics. 18: 096012. PMID 24048367 DOI: 10.1117/1.Jbo.18.9.096012  0.366
2013 Veluswamy RR, Mhango G, Bonomi M, Neugut AI, Hershman DL, Aldridge MD, Wisnivesky JP. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection Annals of the American Thoracic Society. 10: 622-628. PMID 24024700 DOI: 10.1513/Annalsats.201305-127Oc  0.363
2013 Bashir S, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL, Wright JD. Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier. Diseases of the Colon and Rectum. 56: 1174-84. PMID 24022535 DOI: 10.1097/Dcr.0B013E31829Ec889  0.33
2013 Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SN, Lu YS, Neugut AI, Hershman DL. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstetrics and Gynecology. 122: 233-41. PMID 23969789 DOI: 10.1097/Aog.0B013E318299A6Cf  0.302
2013 Galic V, Schiavone MB, Herzog TJ, Holcomb K, Lewin SN, Lu YS, Neugut AI, Hershman DL, Wright JD. Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium. Cancer Investigation. 31: 500-4. PMID 23915075 DOI: 10.3109/07357907.2013.820321  0.32
2013 Spencer BA, McBride RB, Hershman DL, Buono D, Herr HW, Benson MC, Gupta-Mohile S, Neugut AI. Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 9: 92-8. PMID 23814517 DOI: 10.1200/Jop.2011.000480  0.367
2013 Wright JD, Neugut AI, Lewin SN, Lu YS, Herzog TJ, Hershman DL. Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstetrics and Gynecology. 121: 1217-25. PMID 23812455 DOI: 10.1097/Aog.0B013E31828Ec686  0.384
2013 Winner M, Mooney SJ, Hershman DL, Feingold DL, Allendorf JD, Wright JD, Neugut AI. Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. Jama Surgery. 148: 715-22. PMID 23740130 DOI: 10.1001/Jamasurg.2013.1  0.435
2013 Winner M, Mooney SJ, Hershman DL, Feingold DL, Allendorf JD, Wright JD, Neugut AI. Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study. Diseases of the Colon and Rectum. 56: 834-43. PMID 23739189 DOI: 10.1097/Dcr.0B013E318294Ed6B  0.437
2013 Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2627-33. PMID 23733756 DOI: 10.1200/Jco.2012.44.8738  0.395
2013 Kroenke CH, Kwan ML, Neugut AI, Ergas IJ, Wright JD, Caan BJ, Hershman D, Kushi LH. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Research and Treatment. 139: 515-27. PMID 23657404 DOI: 10.1007/S10549-013-2477-2  0.301
2013 Perera HK, Ananth CV, Richards CA, Neugut AI, Lewin SN, Lu YS, Herzog TJ, Hershman DL, Wright JD. Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstetrics and Gynecology. 121: 717-26. PMID 23635670 DOI: 10.1097/Aog.0B013E3182887A47  0.319
2013 Oberstein PE, Hershman DL, Khanna LG, Chabot JA, Insel BJ, Neugut AI. Uptake and patterns of use of gemcitabine for metastatic pancreatic cancer: A population-based study Cancer Investigation. 31: 316-322. PMID 23614655 DOI: 10.3109/07357907.2013.789904  0.41
2013 Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, Brafman L, Jayasena R, Tsai WY, Neugut AI, Crew KD. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Research and Treatment. 138: 795-806. PMID 23542954 DOI: 10.1007/S10549-013-2486-1  0.439
2013 Sharma C, Deutsch I, Herzog TJ, Lu YS, Neugut AI, Lewin SN, Chao CK, Hershman DL, Wright JD. Patterns of care for locally advanced vulvar cancer. American Journal of Obstetrics and Gynecology. 209: 60.e1-5. PMID 23507548 DOI: 10.1016/J.Ajog.2013.03.013  0.424
2013 Greenlee HA, Crew KD, Mata JM, McKinley PS, Rundle AG, Zhang W, Liao Y, Tsai WY, Hershman DL. A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obesity (Silver Spring, Md.). 21: 65-76. PMID 23505170 DOI: 10.1002/Oby.20245  0.391
2013 Wright JD, Deutsch I, Wilde ET, Ananth CV, Neugut AI, Lewin SN, Siddiq Z, Herzog TJ, Hershman DL. Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer. Gynecologic Oncology. 130: 43-8. PMID 23500087 DOI: 10.1016/J.Ygyno.2013.03.006  0.332
2013 Wright JD, Neugut AI, Ananth CV, Lewin SN, Wilde ET, Lu YS, Herzog TJ, Hershman DL. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. Jama Internal Medicine. 173: 559-68. PMID 23460379 DOI: 10.1001/Jamainternmed.2013.2921  0.357
2013 Vin-Raviv N, Hillyer GC, Hershman DL, Galea S, Leoce N, Bovbjerg DH, Kushi LH, Kroenke C, Lamerato L, Ambrosone CB, Valdimorsdottir H, Jandorf L, Mandelblatt JS, Tsai WY, Neugut AI. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. Journal of the National Cancer Institute. 105: 563-72. PMID 23434900 DOI: 10.1093/Jnci/Djt024  0.366
2013 Matushansky I, Dela Cruz F, Insel BJ, Hershman DL, Neugut AI. Chemotherapy use in elderly patients with soft tissue sarcoma: a population-based study. Cancer Investigation. 31: 83-91. PMID 23320812 DOI: 10.3109/07357907.2012.756112  0.36
2013 Zirpoli GR, Brennan PM, Hong CC, McCann SE, Ciupak G, Davis W, Unger JM, Budd GT, Hershman DL, Moore HC, Stewart J, Isaacs C, Hobday T, Salim M, Hortobagyi GN, et al. Supplement use during an intergroup clinical trial for breast cancer (S0221). Breast Cancer Research and Treatment. 137: 903-13. PMID 23306462 DOI: 10.1007/S10549-012-2400-2  0.386
2013 Unger JM, Hershman DL, Albain KS, Moinpour CM, Petersen JA, Burg K, Crowley JJ. Patient income level and cancer clinical trial participation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 536-42. PMID 23295802 DOI: 10.1200/Jco.2012.45.4553  0.354
2013 Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1303-11. PMID 23292697 DOI: 10.1007/S00520-012-1666-6  0.375
2013 Mooney SJ, Winner M, Hershman DL, Wright JD, Feingold DL, Allendorf JD, Neugut AI. Bowel obstruction in elderly ovarian cancer patients: a population-based study. Gynecologic Oncology. 129: 107-12. PMID 23274561 DOI: 10.1016/J.Ygyno.2012.12.028  0.452
2013 Shelton RC, Clarke Hillyer G, Hershman DL, Leoce N, Bovbjerg DH, Mandelblatt JS, Kushi LH, Lamerato L, Nathanson SD, Ambrosone CB, Neugut AI. Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Research and Treatment. 137: 817-28. PMID 23263696 DOI: 10.1007/S10549-012-2370-4  0.405
2013 Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, Kushi LH, Habel LA, Kolevska T, Caan BJ, Gomez SL. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Research and Treatment. 137: 247-60. PMID 23139057 DOI: 10.1007/S10549-012-2329-5  0.448
2013 Greenlee H, Crew KD, Shao T, Kranwinkel G, Kalinsky K, Maurer M, Brafman L, Insel B, Tsai WY, Hershman DL. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1077-87. PMID 23111941 DOI: 10.1007/S00520-012-1628-Z  0.344
2013 Hillyer GC, Hershman DL, Kushi LH, Lamerato L, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Rana S, Neugut AI. A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. Breast (Edinburgh, Scotland). 22: 548-54. PMID 23107518 DOI: 10.1016/J.Breast.2012.10.001  0.453
2013 Awada A, Dirix L, Manso Sanchez L, Xu B, Luu T, Diéras V, Hershman DL, Agrapart V, Ananthakrishnan R, Staroslawska E. Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 109-16. PMID 22967996 DOI: 10.1093/Annonc/Mds284  0.32
2013 Oberstein PE, Hershman DL, Chabot JA, Khanna L, Insel BJ, Neugut AI. Uptake and patterns of use of gemcitabine for stage IV pancreatic cancer Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E15074  0.43
2013 Hershman DL, Neugut AI, Buono D, Richards CA, Glied SA, Wright JD. Off-label and compendia use of chemotherapy in patients with metastatic cancer. Journal of Clinical Oncology. 31: 6509-6509. DOI: 10.1200/Jco.2013.31.15_Suppl.6509  0.427
2013 Wright JD, Neugut AI, Siddiq Z, Glied SA, Hershman DL. Use of high-intensity surveillance in patients following a diagnosis of stage I-II non-small cell lung cancer. Journal of Clinical Oncology. 31: 6505-6505. DOI: 10.1200/Jco.2013.31.15_Suppl.6505  0.347
2013 Kalinsky K, Lim EA, Andreopoulou E, Desai AM, Wang A, Maurer MA, Crew KD, Greenlee H, Hibshoosh H, Sparano JA, Hershman DL. Ethnic differences in tumor proliferation in women with early-stage breast cancer. Journal of Clinical Oncology. 31: 560-560. DOI: 10.1200/Jco.2013.31.15_Suppl.560  0.381
2013 Pothuri B, Muggia F, Sparano JA, Blank SV, Curtin JP, Chuang E, Hershman DL, Chen A, Liebes L. Dose-dependent pharmacokinetic (PK) interaction of pegylated liposomal doxorubicin (PLD) with escalating doses of veliparib in a phase I study. Journal of Clinical Oncology. 31: 2591-2591. DOI: 10.1200/Jco.2013.31.15_Suppl.2591  0.311
2013 Andreopoulou E, Vigoda IS, Valero V, Hershman DL, Raptis G, Vahdat LT, Han HS, Wright JJ, Pellegrino CM, Alvarez RH, Fehn K, Fineberg S, Sparano JA. A phase I-II study of tipifarnib plus weekly paclitaxel (P) followed by dose-dense doxorubicin/cyclophosphamide (AC) in stage IIb-IIIc breast cancer (BC). Journal of Clinical Oncology. 31: 1118-1118. DOI: 10.1200/Jco.2013.31.15_Suppl.1118  0.358
2013 Goodwin PJ, Parulekar W, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee SD, Chalchal HI, et al. Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC). Journal of Clinical Oncology. 31: 1033-1033. DOI: 10.1200/Jco.2013.31.15_Suppl.1033  0.342
2013 Sivasubramanian PS, Xiao T, Hershman DL, Maurer M, Kalinsky K, Feldman S, Brafman L, Refice S, Kranwinkel G, Crew KD. Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-C28  0.398
2013 Greenlee H, Gaffney AO, Aycinena AC, Koch P, Contento I, Karmally W, Richardson J, Lim E, Tsai WY, Crew K, Maurer M, Kalinsky K, Hershman DL. Abstract B02: ¡Cocinar Para Su Salud!: Long-term effects of a short-term culturally based dietary intervention among Hispanic breast cancer survivors Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-B02  0.436
2013 Kalinsky K, Chi D, Lee S, Tiersten A, Makower D, Chuang E, Crew KD, Hershman DL, Silva J, Califano A, Maurer M. Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Ot1-1-09  0.422
2013 Irwin M, Cartmel B, Gross C, Ercolano E, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J. Abstract S3-03: Randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer: The hormones and physical exercise (HOPE) study Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-S3-03  0.378
2013 Sivasubramanian P, Reimers L, Greenlee H, Terry M, Hershman D, Maurer M, Kalinsky K, Awad D, Xiao T, Sandoval R, Alvarez M, Quirarte A, Campbell J, Crew K. Abstract P5-13-01: Uptake of breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ. Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-13-01  0.414
2013 Kalinsky K, Baer L, Tsai W, Ngan M, Feldman S, Taback B, Ananthakrishnan P, Chen-Seetoo M, Hibshoosh H, Crew K, Maurer M, Hershman D. Abstract OT2-6-06: Pre-surgical “window of opportunity” trial of metformin and atorvastatin in newly diagnosed operable breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Ot2-6-06  0.437
2013 Maurer M, Kalinsky K, Forman J, Jayasena R, Crew K, Hershman D. Abstract OT1-4-03: Phase I study of erlotinib and metformin in triple negative breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Ot1-4-03  0.391
2013 Gunther JE, Lim E, Kim HK, Flexman M, Brown M, Refrice S, Kalinsky K, Hershman D, Hielscher AH. Using diffuse optical tomograpy to monitor tumor response to neoadjuvant chemotherapy in breast cancer patients Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8578. DOI: 10.1117/12.2003111  0.421
2013 Wright J, Ananth C, Herzog T, Burke W, Lu Y, Lewin S, Neugut A, Hershman D. Comparative effectiveness of upfront treatment strategies for advanced-stage ovarian cancer Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.337  0.378
2013 Mahany EB, Hershman DL, Sauer MV, Choi JM. Pregnancy despite ovarian insufficiency in a patient with breast cancer Reproductive Medicine and Biology. 12: 35-38. DOI: 10.1007/s12522-012-0133-x  0.375
2012 Lichtensztajn D, Keegan TH, Leung RW, Shema SJ, Hershman DL, Kushi LH, Habel LA, Kolevska T, Caan BJ, Gomez SL. Patterns and predictors of chemotherapy and trastuzumab use for early-stage breast cancer in Kaiser Permanente Northern California, 2004-2007. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 256. PMID 28147095 DOI: 10.1200/Jco.2012.30.34_Suppl.256  0.447
2012 Wright JD, Neugut AI, Wilde ET, Buono DL, Tsai WY, Hershman DL. Use and benefits of laparoscopic hysterectomy for stage I endometrial cancer among medicare beneficiaries. Journal of Oncology Practice / American Society of Clinical Oncology. 8: e89-99. PMID 23277777 DOI: 10.1200/Jop.2011.000484  0.372
2012 Hillyer GC, Neugut AI, Crew KD, Kalinsky K, Maurer MA, Rotsides DZ, Danaceau J, Hershman DL. Use of a urine anastrozole assay to determine treatment discontinuation among women with hormone-sensitive breast cancer: A pilot study Journal of Oncology Practice. 8: e100-e104. PMID 23277771 DOI: 10.1200/Jop.2011.000487  0.435
2012 Rogo-Gupta L, Rodriguez LV, Litwin MS, Herzog TJ, Neugut AI, Lu YS, Raz S, Hershman DL, Wright JD. Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstetrics and Gynecology. 120: 1105-15. PMID 23090529 DOI: 10.1097/Aog.0B013E31826Ebcc2  0.323
2012 Hershman DL, Richards CA, Kalinsky K, Wilde ET, Lu YS, Ascherman JA, Neugut AI, Wright JD. Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Research and Treatment. 136: 535-45. PMID 23053659 DOI: 10.1007/S10549-012-2273-4  0.393
2012 Wright JD, Herzog TJ, Siddiq Z, Arend R, Neugut AI, Burke WM, Lewin SN, Ananth CV, Hershman DL. Failure to rescue as a source of variation in hospital mortality for ovarian cancer Journal of Clinical Oncology. 30: 3976-3982. PMID 23032619 DOI: 10.1200/Jco.2012.43.2906  0.327
2012 Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL. Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3800-9. PMID 23008305 DOI: 10.1200/Jco.2012.43.8168  0.482
2012 Wright JD, Herzog TJ, Neugut AI, Burke WM, Lu YS, Lewin SN, Hershman DL. Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer Obstetrics and Gynecology. 120: 871-881. PMID 22996105 DOI: 10.1097/Aog.0B013E31826981De  0.401
2012 Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky J, Halazun K, Dove L, Brown RS, Neugut AI, Kato T, et al. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation. 94: 539-43. PMID 22864187 DOI: 10.1097/Tp.0B013E31825C58Ea  0.318
2012 Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, ... ... Hershman DL, et al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prevention Research (Philadelphia, Pa.). 5: 1144-54. PMID 22827973 DOI: 10.1158/1940-6207.Capr-12-0117  0.372
2012 Wright JD, Herzog TJ, Neugut AI, Burke WM, Lu YS, Lewin SN, Hershman DL. Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer Gynecologic Oncology. 127: 11-17. PMID 22735788 DOI: 10.1016/J.Ygyno.2012.06.031  0.31
2012 Kalinsky K, Hershman DL. Cracking open window of opportunity trials Journal of Clinical Oncology. 30: 2573-2575. PMID 22565006 DOI: 10.1200/Jco.2012.42.3293  0.427
2012 Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Research and Treatment. 134: 419-28. PMID 22527111 DOI: 10.1007/S10549-012-2066-9  0.449
2012 Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. The Breast Journal. 18: 203-13. PMID 22487337 DOI: 10.1111/J.1524-4741.2012.01240.X  0.44
2012 Hershman DL, Wilde ET, Wright JD, Buono DL, Kalinsky K, Malin JL, Neugut AI. Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer Journal of Clinical Oncology. 30: 806-812. PMID 22312106 DOI: 10.1200/Jco.2011.37.7499  0.303
2012 Wright JD, Burke WM, Wilde ET, Lewin SN, Charles AS, Kim JH, Goldman N, Neugut AI, Herzog TJ, Hershman DL. Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 783-91. PMID 22291073 DOI: 10.1200/Jco.2011.36.7508  0.342
2012 Berger-Chen S, Herzog TJ, Lewin SN, Burke WM, Neugut AI, Hershman DL, Wright JD. Access to conservative surgical therapy for adolescents with benign ovarian masses Obstetrics and Gynecology. 119: 270-275. PMID 22270278 DOI: 10.1097/Aog.0B013E318242637A  0.358
2012 Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, Hershman DL, Wright JD. Prognostic significance of adenocarcinoma histology in women with cervical cancer Gynecologic Oncology. 125: 287-291. PMID 22266551 DOI: 10.1016/J.Ygyno.2012.01.012  0.375
2012 Sharma C, Deutsch I, Horowitz DP, Hershman DL, Lewin SN, Lu YS, Neugut AI, Herzog TJ, Chao CK, Wright JD. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 118: 3618-26. PMID 22038773 DOI: 10.1002/Cncr.26589  0.441
2012 Wright JD, Hershman DL, Burke WM, Lu YS, Neugut AI, Lewin SN, Herzog TJ. Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer Annals of Surgical Oncology. 19: 948-958. PMID 21989660 DOI: 10.1245/S10434-011-2090-8  0.349
2012 Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, Neugut AI, Fehrenbacher L, Thompson B, Coronado GD. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 131: 607-17. PMID 21922245 DOI: 10.1007/S10549-011-1762-1  0.45
2012 Flexman ML, Gunther J, Kim HK, Lim E, Desperito E, Barbour RL, Hershman DL, Hielscher AH. Diffuse optical tomography imaging of the hemodynamic response to a breath hold for use in breast cancer detection Digital Holography and Three-Dimensional Imaging, Dh 2012. JM3A.69. DOI: 10.1364/Biomed.2012.Jm3A.69  0.33
2012 Hershman DL, Wright JD, Neugut AI. Reply to C.A. Hudis et al Journal of Clinical Oncology. 30: 3150. DOI: 10.1200/Jco.2012.43.8192  0.388
2012 Unger JM, Hershman DL, Burg K, Moinpour C, Albain KS, Petersen JA, Crowley J. Patterns of decision making about cancer clinical trial participation among the online cancer treatment community: A collaboration between SWOG and NexCura. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.18_Suppl.Cra6009  0.371
2012 Irwin M, Cartmel B, Ercolano E, Fiellin M, Rothbard M, Capozza S, Zhou Y, Schmitz K, Ligibel JA, Hershman DL, Neogi T, Gross CP. Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.Tps669  0.4
2012 Hershman DL, Unger JM, Crew KD, Moinpour C, Minasian LM, Hansen L, Lew D, OKane P, Wade JL, Wong S, Hortobagyi GN, Meyskens FL, Albain KS. SWOG S0715: Randomized placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy. Journal of Clinical Oncology. 30: 9018-9018. DOI: 10.1200/Jco.2012.30.15_Suppl.9018  0.38
2012 Richards CA, Wright JD, Neugut AI, Ascherman J, Hershman DL. Influence of hospital characteristics on immediate breast reconstruction following mastectomy. Journal of Clinical Oncology. 30: 6118-6118. DOI: 10.1200/Jco.2012.30.15_Suppl.6118  0.324
2012 Wright JD, Neugut AI, Lewin SN, Burke WM, Lu Y, Herzog TJ, Hershman DL. Deviations from guideline-based therapy for febrile neutropenia in cancer patients. Journal of Clinical Oncology. 30: 6078-6078. DOI: 10.1200/Jco.2012.30.15_Suppl.6078  0.388
2012 Xu X, Shen Y, Dewitt W, Pandya D, Bischoff FZ, Crew KD, Hershman DL, Maurer MA, Parsons R, Kalinsky K. Mutational analysis of circulating tumor cells in breast cancer patients by targeted clonal sequencing. Journal of Clinical Oncology. 30: 10516-10516. DOI: 10.1200/Jco.2012.30.15_Suppl.10516  0.357
2012 Delgado-Cruzata L, Zhang W, Tsai WY, Valdovinos C, Wang Q, Crew K, Santella R, Hershman D, Greenlee H. Abstract 4482: Effects of lifestyle modification on global DNA methylation in minority breast cancer survivors Epidemiology. 72: 4482-4482. DOI: 10.1158/1538-7445.Am2012-4482  0.373
2012 Wright J, Herzog T, Neugut A, Burke W, Lu Y, Lewin S, Hershman D. Comparative effectiveness of minimally invasive radical hysterectomy for cervical cancer Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.141  0.349
2012 Pothuri B, Sparano J, Blank S, Curtin J, Chuang E, Hershman D, Tiersten A, Liebes L, Chen A, Muggia F. Phase I study of the PARP inhibitor ABT-888 (veliparib) and pegylated liposomal doxorubicin (PLD) in recurrent ovarian (ov) and breast (br) cancers Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.053  0.424
2012 Wright JD, Herzog TJ, Hershman DL. Defining the limits of radical cytoreductive surgery for ovarian cancer Gynecologic Oncology. 125: 508-509. DOI: 10.1016/J.Ygyno.2011.08.027  0.398
2012 Spencer B, Neugut A, Hershman D, Insel B, Benson M. 941 Intermittent Vs. Continuous Androgen Deprivation Therapy Among Elderly Patients With Advanced Prostate Cancer The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1039  0.339
2012 Spencer B, Insel B, Hershman D, Benson M, Neugut A. 938 Patterns Of Care In The Use Of Palliative Therapy For Ureteral Obstruction Among Elderly Patients With Advanced Prostate Cancer The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1036  0.39
2012 Becker D, Hershman DL. Adjuvant therapy for elderly patients with breast, colon, and lung cancer Management of Cancer in the Older Patient. 79-88. DOI: 10.1016/B978-1-4377-1398-5.10008-6  0.309
2011 Parulekar W, Chen BE, Elliott C, Shepherd LE, Gelmon KA, Pritchard KI, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Lemieux J, Ganz PA, Stambolic V, et al. A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: TPS103. PMID 28022859 DOI: 10.1200/Jco.2011.29.15_Suppl.Tps103  0.362
2011 Wright JD, Hershman DL, Shah M, Burke WM, Sun X, Neugut AI, Lewin SN, Herzog TJ. Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery Obstetrics and Gynecology. 118: 978-986. PMID 22015864 DOI: 10.1097/Aog.0B013E31822C952A  0.361
2011 Wright JD, Neugut AI, Wilde ET, Buono DL, Malin J, Tsai WY, Hershman DL. Physician characteristics and variability of erythropoiesis-stimulating agent use among medicare patients with cancer Journal of Clinical Oncology. 29: 3408-3418. PMID 21810679 DOI: 10.1200/Jco.2010.34.5462  0.394
2011 Flexman ML, Khalil MA, Al Abdi R, Kim HK, Fong CJ, Desperito E, Hershman DL, Barbour RL, Hielscher AH. Digital optical tomography system for dynamic breast imaging. Journal of Biomedical Optics. 16: 076014. PMID 21806275 DOI: 10.1117/1.3599955  0.368
2011 Sucheston LE, Zhao H, Yao S, Zirpoli G, Liu S, Barlow WE, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, et al. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Research and Treatment. 130: 993-1002. PMID 21766209 DOI: 10.1007/S10549-011-1671-3  0.419
2011 Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, Grann VR, Hershman DL. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer Journal of Clinical Oncology. 29: 2534-2542. PMID 21606426 DOI: 10.1200/Jco.2010.33.3179  0.408
2011 Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Research and Treatment. 125: 767-74. PMID 21128110 DOI: 10.1007/S10549-010-1278-0  0.366
2011 Goodwin PJ, Stambolic V, Lemieux J, Chen BE, Parulekar WR, Gelmon KA, Hershman DL, Hobday TJ, Ligibel JA, Mayer IA, Pritchard KI, Whelan TJ, Rastogi P, Shepherd LE. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Research and Treatment. 126: 215-20. PMID 20976543 DOI: 10.1007/S10549-010-1224-1  0.449
2011 Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Kwan M, Gomez SL, Neugut AI. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment. 126: 529-37. PMID 20803066 DOI: 10.1007/S10549-010-1132-4  0.364
2011 Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, Hershman DL, Neugut AI. Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Research and Treatment. 125: 837-47. PMID 20644999 DOI: 10.1007/S10549-010-1043-4  0.32
2011 Kalinsky K, Sparano JA, Andreopoulou E, Taback B, Wiechmann LS, Feldman SM, Ananthakrishnan P, Hibshoosh H, Manavalan J, Crew KD, Maurer MA, Hershman DL. Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer. Journal of Clinical Oncology. 29: 2613-2613. DOI: 10.1200/Jco.2011.29.15_Suppl.Tps147  0.38
2011 Crew KD, Lippman S, Hershman DL, Brown P, Greenlee H, Bevers T, Arun B, Hudis C, McArthur H, Vornik L, Cornelison T. Abstract CN06-02: Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with a history of hormone receptor-negative breast cancer Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Cn06-02  0.452
2011 Reimers LL, Hershman DL, Maurer M, Kalinsky K, Brafman L, Kranwinkel G, Crew KD. Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A48  0.442
2011 Zirpoli GR, Brennan PM, Hong C, McCann SE, Unger JM, Budd GT, Hershman DL, Stewart J, Isaacs C, Hobday T, Salim M, Hortobagyi GN, Gralow J, Albain K, Hayes DF, et al. Abstract 4681: Effect of physician recommendation on multivitamin and antioxidant supplement use during chemotherapy in an adjuvant trial for breast cancer (SWOG S0221) Cancer Research. 71: 4681-4681. DOI: 10.1158/1538-7445.Am2011-4681  0.396
2011 Flexman M, Kim H, Lim E, Desperito E, Barbour R, Hershman D, Hielscher A. P2-10-09: Detecting Breast Cancer with Dynamic Diffuse Optical Tomographic Imaging. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-10-09  0.375
2011 Maurer M, Kalinsky K, Crew K, Jayasena R, Forman J, Lau Y-, Shaw J, Parsons R, Hershman D. OT3-01-13: Phase One Trial of Combined Temsirolimus, Erlotinib, and Cisplatin in Advanced Solid Tumors. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Ot3-01-13  0.348
2011 Hershman D, Unger J, Crew K, Moinpour C, Minasian L, Hansen L, Lew D, Kaberle K, Wade J, Meyskens F. OT2-07-02: SWOG S0927: A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (AI)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Ot2-07-02  0.435
2011 Flexman ML, Khalil MA, Al Abdi RM, Reig B, Fong CJ, Hershman D, Desperito E, Barbour RL, Hielscher AH. Optical tomographic imaging of the hemodynamic response to a breath hold in breast cancer patients Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7896. DOI: 10.1117/12.875461  0.408
2010 Fasano J, Hershman D, Novik Y, Levinson B, Blozie K, Tiersten AD. Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer. Breast Care. 5: 17-21. PMID 22619636 DOI: 10.1159/000272119  0.406
2010 Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Gomez SL, Miles S, Neugut AI. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4120-8. PMID 20585090 DOI: 10.1200/Jco.2009.25.9655  0.421
2010 Goldsmith RE, Jandorf L, Valdimarsdottir H, Amend KL, Stoudt BG, Rini C, Hershman D, Neugut A, Reilly JJ, Tartter PI, Feldman SM, Ambrosone CB, Bovbjerg DH. Traumatic stress symptoms and breast cancer: the role of childhood abuse. Child Abuse & Neglect. 34: 465-70. PMID 20400179 DOI: 10.1016/J.Chiabu.2009.10.007  0.397
2010 McBride RB, Lebwohl B, Hershman DL, Neugut AI. Impact of socioeconomic status on extent of lymph node dissection for colon cancer Cancer Epidemiology Biomarkers and Prevention. 19: 738-745. PMID 20200428 DOI: 10.1158/1055-9965.Epi-09-1086  0.377
2010 Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, Hershman DL. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy Cancer. 116: 2099-2105. PMID 20187091 DOI: 10.1002/Cncr.25037  0.397
2010 Lai R, Hershman DL, Doan T, Neugut AI. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro-Oncology. 12: 190-8. PMID 20150386 DOI: 10.1093/Neuonc/Nop004  0.309
2010 Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP, Neugut AI, Hershman DL, Mandelblatt J, Pelayo MP, Timperi AW, Miles SQ, Kushi LH. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Research and Treatment. 123: 507-24. PMID 20140494 DOI: 10.1007/S10549-010-0764-8  0.464
2010 Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1154-60. PMID 20100963 DOI: 10.1200/Jco.2009.23.4708  0.37
2010 Hershman DL, McMahon DJ, Crew KD, Shao T, Cremers S, Brafman L, Awad D, Shane E. Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment Journal of Clinical Endocrinology and Metabolism. 95: 559-566. PMID 20022990 DOI: 10.1210/Jc.2009-1366  0.356
2010 Kuo DY, Blank SV, Christos PJ, Kim M, Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD, Muggia F, Goldberg GL, Einstein MH. Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study. Gynecologic Oncology. 116: 442-6. PMID 19931137 DOI: 10.1016/j.ygyno.2009.10.082  0.311
2010 Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Research and Treatment. 123: 25-34. PMID 19894112 DOI: 10.1007/S10549-009-0606-8  0.357
2010 Strauss J, Hershman DL, Buono D, McBride R, Clark-Garvey S, Woodhouse SA, Abrams JA, Neugut AI. Use of Adjuvant 5-Fluorouracil and Radiation Therapy After Gastric Cancer Resection Among the Elderly and Impact on Survival International Journal of Radiation Oncology Biology Physics. 76: 1404-1412. PMID 19540074 DOI: 10.1016/J.Ijrobp.2009.03.050  0.376
2010 Grann VR, Patel P, Bharthuar A, Jacobson JS, Warner E, Anderson K, Warner E, Tsai WY, Hill KA, Neugut AI, Hershman D. Breast cancer-related preferences among women with and without BRCA mutations. Breast Cancer Research and Treatment. 119: 177-84. PMID 19322653 DOI: 10.1007/S10549-009-0373-6  0.39
2010 Campbell JL, Cardelli J, McLarty J, Hershman D, Taback B, Refice S, Wang S, Bigelow R, Crew K. Abstract PR-05: Effects of presurgical administration of tea polyphenols in women with operable breast cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-Pr-05  0.472
2010 Refice S, Hershman D, Maurer M, Kalinsky K, Feldman S, Brafman L, Crew K. Abstract P1-07-01: Safety of High-Dose Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P1-07-01  0.381
2009 Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. Journal of the National Cancer Institute. 101: 1633-41. PMID 19903808 DOI: 10.1093/Jnci/Djp387  0.331
2009 Fu OS, Crew KD, Jacobson JS, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman DL. Ethnicity and persistent symptom burden in breast cancer survivors. Journal of Cancer Survivorship : Research and Practice. 3: 241-50. PMID 19859813 DOI: 10.1007/S11764-009-0100-7  0.352
2009 Abrams JA, Buono DL, Strauss J, McBride RB, Hershman DL, Neugut AI. Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly Cancer. 115: 4924-4933. PMID 19637343 DOI: 10.1002/Cncr.24536  0.434
2009 Albain KS, Unger JM, Crowley JJ, Coltman CA, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. Journal of the National Cancer Institute. 101: 984-92. PMID 19584328 DOI: 10.1093/Jnci/Djp175  0.484
2009 Hershman DL, Buono D, McBride RB, Tsai WY, Neugut AI. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women. Cancer. 115: 3848-57. PMID 19517470 DOI: 10.1002/Cncr.24448  0.457
2009 Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer. 115: 3271-82. PMID 19507173 DOI: 10.1002/Cncr.24378  0.443
2009 Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prevention Research (Philadelphia, Pa.). 2: 598-604. PMID 19470790 DOI: 10.1158/1940-6207.Capr-08-0138  0.394
2009 Hershman DL, Shao T. Anthracycline cardiotoxicity after breast cancer treatment Oncology. 23: 227-234. PMID 19418823  0.371
2009 Hershman DL, Buono D, Jacobson JS, McBride RB, Tsai WY, Joseph KA, Neugut AI. Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Annals of Surgery. 249: 828-33. PMID 19387318 DOI: 10.1097/Sla.0B013E3181A38F6F  0.336
2009 Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, et al. Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2942-8. PMID 19351752 DOI: 10.1158/1078-0432.Ccr-08-2658  0.466
2009 Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy Journal of Clinical Oncology. 27: 2151-2156. PMID 19349547 DOI: 10.1200/Jco.2008.19.6162  0.378
2009 Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS. Treatment quality and outcomes of African American versus white breast cancer patients: Retrospective analysis of southwest oncology studies S8814/S8897 Journal of Clinical Oncology. 27: 2157-2162. PMID 19307504 DOI: 10.1200/Jco.2008.19.1163  0.449
2009 Hershman DL, Cho C, Crew KD. Management of complications from estrogen deprivation in breast cancer patients Current Oncology Reports. 11: 29-36. PMID 19080739 DOI: 10.1007/S11912-009-0006-6  0.466
2009 Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Research and Treatment. 115: 437-52. PMID 18839308 DOI: 10.1007/S10549-008-0193-0  0.453
2009 Ramaswamy B, Bhalla K, Cohen B, Pellegrino C, Hershman D, Chuang E, Somlo G, Goetz M, Swaby R, Hopkins U, Christos P, Espinoza-Delgado I, Sparano J. Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703. Cancer Research. 69: 404. DOI: 10.1158/0008-5472.Sabcs-404  0.361
2009 Yu B, Lobo R, Crew K, Ferin M, Douglas N, Nakhuda G, Hershman D. Predictive markers of chemotherapy-induced menopause in premenopausal women under the age of 40 with breast cancer. Cancer Research. 69: 1118. DOI: 10.1158/0008-5472.Sabcs-1118  0.413
2009 Crew K, Weimer L, Brafman L, Fuentes D, Awad D, Hershman D. Prospective Evaluation of Neurotoxicity in Breast Cancer Patients Treated with Adjuvant Paclitaxel. Cancer Research. 69: 807-807. DOI: 10.1158/0008-5472.Sabcs-09-807  0.444
2009 Crew K, Podolanczuk A, Brafman L, Awad D, Hershman D. Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer. Cancer Research. 69: 5044-5044. DOI: 10.1158/0008-5472.Sabcs-09-5044  0.427
2009 Ambrosone C, Sucheston L, Zhao H, Yao S, Budd G, Barlow W, Hershman D, Davis W, Ciupak G, Stewart J, Isaacs C, Hobday T, Latreille J, Hortobagyi G, Gralow J, et al. Variants in the BRCA1/Fanconi-Anemia Repair Pathway and Taxane-Induced Neuropathy in SWOG S0221. Cancer Research. 69: 2001-2001. DOI: 10.1158/0008-5472.Sabcs-09-2001  0.349
2009 Fu O, Crew K, Jacobson J, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman D. Ethnicity, Age, and Employment Associated with Persistent Symptoms in Breast Cancer Survivors. Cancer Research. 69: 1064-1064. DOI: 10.1158/0008-5472.Sabcs-09-1064  0.444
2009 Greenlee H, Crew K, McKinley P, Rundle A, Tsai W, Mata J, Sandoval R, Hershman D. Effects of a Combined Physical Activity and Dietary Change Intervention on Weight Loss in Minority Breast Cancer Survivors. Cancer Research. 69: 1038-1038. DOI: 10.1158/0008-5472.Sabcs-09-1038  0.365
2008 Perez AT, Shaw HS, Fleming GF, Hershman DL, Franco S, Shapiro CL, Neal K, Cohen I, Tagliaferri M, Tripathy D. A phase I trial of scutellaria barbata (BZL101) for metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1099. PMID 27950963 DOI: 10.1200/Jco.2008.26.15_Suppl.1099  0.396
2008 Hershman D, Calhoun E, Zapert K, Wade S, Malin J, Barron R. Patients' Perceptions of Physician-Patient Discussions and Adverse Events with Cancer Therapy Archives of Drug Information. 1: 70-78. PMID 19639029 DOI: 10.1111/J.1753-5174.2008.00011.X  0.393
2008 Hershman DL, McMahon DJ, Crew KD, Cremers S, Irani D, Cucchiara G, Brafman L, Shane E. Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer Journal of Clinical Oncology. 26: 4739-4745. PMID 18711172 DOI: 10.1200/Jco.2008.16.4707  0.383
2008 Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS, Horwitz MS, Bowman N, Beckmann K, Hershman DL. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. British Journal of Haematology. 143: 288-93. PMID 18710383 DOI: 10.1111/J.1365-2141.2008.07335.X  0.324
2008 Hershman DL, Neugut AI. Anthracycline cardiotoxicity: One size does not fit all! Journal of the National Cancer Institute. 100: 1046-1047. PMID 18664649 DOI: 10.1093/Jnci/Djn241  0.416
2008 Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3159-65. PMID 18591554 DOI: 10.1200/Jco.2007.14.1242  0.323
2008 Grann VR, Bowman N, Joseph C, Wei Y, Horwitz MS, Jacobson JS, Santella RP, Hershman DL. Neutropenia in 6 ethnic groups from the Caribbean and the U.S. Cancer. 113: 854-60. PMID 18543314 DOI: 10.1002/Cncr.23614  0.363
2008 Hershman DL. Getting a grip on aromatase inhibitor - Associated arthralgias Journal of Clinical Oncology. 26: 3120-3121. PMID 18474872 DOI: 10.1200/Jco.2008.16.7684  0.37
2008 Wright J, Doan T, McBride R, Jacobson J, Hershman D. Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. British Journal of Cancer. 98: 1197-203. PMID 18349836 DOI: 10.1038/Sj.Bjc.6604298  0.41
2008 Cohen A, Fleischer JB, Johnson MK, Brown IN, Joe AK, Hershman DL, McMahon DJ, Silverberg SJ. Prevention of bone loss after withdrawal of tamoxifen. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 14: 162-7. PMID 18308653 DOI: 10.4158/Ep.14.2.162  0.391
2008 Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, Jacobson JS. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. Journal of the National Cancer Institute. 100: 199-206. PMID 18230795 DOI: 10.1093/Jnci/Djm320  0.458
2008 Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 392-8. PMID 18202415 DOI: 10.1200/Jco.2007.13.3033  0.349
Show low-probability matches.